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often rely on the presence ofÂ non-proteinaceous cofactorsÂ to take part in the enzymatic function. Â The
most common,Â central to my thesis,Â is heme B. Â Depending on the protein environment, this cofactor can
take part in functions as diverse as electron transfer (cytochromes), oxygen transport (hemoglobins), oxygen
reduction (oxidases), carbon-hydroxylation (oxygenases), and superoxide production (NADH oxidase).
In natural oxidoreductases, determination of the course and rates of heme-protein association, what barriers
are encountered, what affinity is achieved, and what are the oxidation-reduction potentials,Â is criticalÂ forÂ
understanding the rules ofÂ assembly and function of the different activities performed. In the growing field
of research attempting to make man-made oxidoreductases, the same understanding is required for progress to
be made towardÂ construction of novel enzymes. However, this understanding is still out of reach in natural
oxidoreductasesÂ because of the immenseÂ complexity of natural proteins, while for man-made designs
progress has only recently reached a point where an in-depth systematic study can be contemplated.Â
My thesis states: Simple non-natural proteins (maquettes) designed from first principles to ligate heme, can be
used toÂ uncover the factors derived from theÂ oligomeric andÂ structural state of related maquette and also
derived from porphyrin variants of heme B,Â that govern rates of Â incorporation and ligation ofÂ heme BÂ
into a maquette.Â Maquettes are ideal platforms to demonstrate what aspects of a protein govern heme redox
potentials, a key parameter underlying the diversity of hemoprotein functions. Â
The findings from my work provide the first views of heme and maquette assembly: spontaneous, rapid and
with high affinity association. They also provide a foundation for understanding what controls redox
potentials of the heme and perspective on this control. The work offers insight into similar processes in natural
oxidoreductases,Â but the concepts and principles uncovered in this thesis will be vital in the development
ofÂ novel functions applied in man-made applications in vitro and in vivo.
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Abstract
THE PHYSICAL CHEMISTRY UNDERLYING THE ASSEMBLY AND MIDPOINT 
POTENTIAL CONTROL IN A SERIES OF DESIGNED PROTEIN-MAQUETTES
Lee A. Solomon
P. Leslie Dutton
 In nature, oxidoreductase proteins are responsible for many enzymatic processes 
critical to life. These proteins often rely on the presence of non-proteinaceous cofactors to 
take part in the enzymatic function.  The most common, central to my thesis,  is heme B.  
Depending  on the protein environment, this cofactor can take part in functions as diverse 
as electron transfer (cytochromes), oxygen transport (hemoglobins), oxygen reduction 
(oxidases), carbon-hydroxylation (oxygenases), and superoxide production (NADH 
oxidase).
 In natural oxidoreductases, determination of the course and rates of heme-protein 
association, what barriers are encountered, what affinity is achieved, and what are the 
oxidation-reduction potentials,  is critical  for  understanding  the rules of  assembly and 
function of the different activities performed. In the growing field of research attempting  to 
make man-made oxidoreductases, the same understanding is required for progress to be 
made toward  construction of novel enzymes. However, this understanding  is still out of 
reach in natural oxidoreductases because of the immense complexity of natural proteins, 
while for man-made designs progress has only recently reached a point where an in-depth 
systematic study can be contemplated. 
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 My thesis states: Simple non-natural proteins (maquettes) designed from first 
principles to ligate heme, can be used to uncover the factors derived from the oligomeric 
and structural state of related maquette and also derived from porphyrin variants of heme 
B,  that govern rates of   incorporation and ligation of heme B  into a maquette. Maquettes 
are ideal platforms to demonstrate what aspects of a protein govern heme redox potentials, 
a key parameter underlying the diversity of hemoprotein functions.  
 The findings from my work provide the first views of heme and maquette assembly: 
spontaneous, rapid and with high affinity association. They also provide a foundation for 
understanding  what controls redox potentials of the heme and perspective on this control. 
The work offers insight into similar processes in natural oxidoreductases, but the concepts 
and principles uncovered in this thesis will be vital in the development of novel functions 
applied in man-made applications in vitro and in vivo.  
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Chapter 1: Introduction
1.1: The Heme Cofactor
1.1.1: Heme In Nature
The large family of oxidoreductase proteins often employs a wide variety of 
cofactors capable of taking  part in enzymatic reactions. Organic, inorganic, and in some 
cases amino acids themselves are used to setup  electron transfer pathways to catalyze 
these functions. Making up a large number of oxidoreductase proteins are ones that 
contain a specific cofactor named heme B (Fe-protoporphyrin IX) (Figure 1.1-B).1 This 
cofactor is an iron-centered tetrapyrrole used for a number of functions including 
oxygenases (heme oxygenase),2 cytochrome P450s,3 electron transfer (cytochrome c),4 
small molecule binding  (myoglobin, soluble guanylyl cyclase),5 peroxidases (Cytochrome c 
peroxidase),6 and quinone oxidation and reduction (redox) reactions (cytochrome bc1).7 As 
such, it is critical we have a  deep understanding  of these proteins as they are important to 
cellular viability, and have effects that extend into medical disorders such as 
ophthalmoplegia, and cardiomyopathy.8
Of the many reactions hemoproteins carry out, the respiratory electron transport 
chain reactions are amongst the most prevalent throughout nature (Figure 1.2).9,10 These 
reactions couple electron transfer to proton transport across a membrane generating a large 
electrochemical potential (∆µH+), which is then used to power ATP synthesis.  Heme plays 
a vital role in this process being present in, and integral to the function of, respiratory 
pathway proteins Complex II, III, and IV (Figure 1.2).11 In these proteins it is used to shuttle 
single electrons reduce or oxidize qunione cofactors and reduce O2 to water.10 Heme is 
1
    
2
also present in photosynthetic proteins, most notably cytochrome b6f and Photosystem II.
9,12,13 Again, in these proteins heme is central to electron and proton transfer reactions 
generating a proton gradient for use in ATP synthesis.14
Due to the prevalence of the heme cofactor, and its importance to cellular viability, 
the interactions it has with proteins need to be understood. My thesis describes the 
physical chemistry underlying  assembly of this cofactor with protein and the effect of the 
protein environment on the redox chemistry it takes part in.
1.1.2: Alternative Heme Variants
 Though heme B is the most widely used porphyrin it is not the only one utilized in 
nature. There are a wide variety of tetrapyrroles that display diverse functions. Heme B 
itself is often modified so that its functional range can be expanded. Heme A is an example 
of how heme B is modified in nature to change its function. This cofactor is present in 
cytochrome oxidase in mammals.15,16 This variant has the same tetrapyrrole ring  as heme B 
however its substituents are modified (Figure 1.1-Left). Both heme A and heme O have, at 
2
    
Figure	  1.1:	   From	  Left	   to	   right:	  Heme	  A,	   Heme	  B	   and	  Heme	  C.	   These	   are	   the	  three	  
most	   common	   naturally	   occurring	   heme	   cofactors,	   used	   in	   a	   wide	   variety	   of	  
functions
3
the C3 position, a farnesyl tail, a long hydrophobic chain that is used to anchor the heme 
into a large, membrane bound protein.17 This is in place of a vinyl group present in heme 
B. Heme A also has, at the C18  position, a formyl group in place of a methyl group. This 
electron withdrawing  modification substantially raises the redox midpoint potential to 
make it a potent oxidant. While it is functionally beneficial for these modifications to be 
made, these modifications have inherent complications. Proteins that utilize heme A 
require a large hydrophobic cavity specifically for the farnesyl tail. In nature, as a result of 
these issues, this cofactor is constructed and inserted into cytochrome oxidase through a 
complicated system of protein chaperones. Heme A is controlled by the COX system. It is 
synthesized by COX10 and COX15, and then chaperoned into the appropriate site in the 
protein.17 Due to its higher oxidation potential, this porphyrin is used for oxygen reduction 
seen in cytochrome oxidase and requires extensive modifications far different and more 
complex than a standard heme B protein. 
3
    
Figure	   1.2:	   Mitochondrial	   respiratory	   electron	   transport	   chain.	   A	   proton	   motive	  
force	   (∆µH+)	   is	   generated	   by	   proton	  pumping,	   the	   energy	   for	   which	   is	   obtained	  
through	   electron	   transfer.	   Heme	   cofactors	   are	   represented	   in	   red	   and	   present	  
throughout	  a	  majority	  of	  these	  proteins.
!"#$%&'( !!" !!!" !#" #"!"
$%&'()"
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Heme C is another heme B variant. This variant uses the C3 and C8 vinyl groups as 
points of covalent attachment to a protein that contains a CXXCH motif (Figure 1.1-Right). 
This simple system allows for many different ligands and environments without the worry 
of losing  the heme to solution. This variant requires chemical reactions for its assembly, and 
multiple proteins in the cytochrome-c maturation (CCM) system have evolved to chaperone 
c-heme cofactors into place, and aid in the covalent linkage to the protein.4 With this 
attachment motif proteins retain heme despite not being  optimized for a high affinity. The 
attachment motif greatly expands the range and abilities of many hemoproteins, though the 
complex system of proteins interfere with the study of how proteins affect the assembly of 
hemoproteins.
1.1.3: Alternative Tetrapyrrole Cofactors In Nature
In addition to heme B and its variants there are also many types of porphyrins that 
have both alternate metals and structures. A common tetrapyrrole alternative to heme is the 
chlorin, the basis of chlorophyll pigments central to photosynthesis.18 Chlorophyll is well-
known for its extensive modifications to its ring  structure and a Mg  metal in the center.19 
The metal in the center allows for this pigment to effectively absorb  light and transfer this 
energy through a series of cofactors and proteins eventually leading  to its conversion into 
chemical energy that can be stored by plants.18 
Using  the same starting  material as heme B, these pigments must all be synthesized 
and assembled in the cell on an as needed basis without excess released. Like heme A 
chlorophyll has a large phytyl tail maintaining  them in hydrophobic environments. The 
various assembly processes have been well documented from the initial signaling to final 
4
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cofactor insertion. The fact that heme B precursors are the starting  material only increases 
the importance of understanding  porphyrin interactions with natural proteins, as they lead 
to further understanding of the interactions made between proteins and other modified 
variants of this cofactor.
Photosynthetic and respiratory systems are vital throughout all kingdoms of life, 
and all have the same heme cofactor.10 However, despite this importance, tetrapyrrole 
cofactors are toxic if it is not in an appropriate protein environment.11 Because of this 
problem, their concentration is highly regulated (both acquisition and removal), which will 
be described below.
 1.1.4: Heme Regulation In The Cell
 Many organisms employ systems of acquisition and transport in order to get heme 
B into the cell. The ISD (iron-responsive surface determinant) proteins in Staphylococcus 
aureus are one such example (Figure 1.3).20 These proteins are membrane transporters that 
bind hemoproteins in the exterior environment and transport them across the membrane. 
Once heme is in the cell many other proteins of this system dismantle the holoprotein and 
shuttle the heme to either an apoprotein or to heme oxygenase for degradation. Another 
example is the hemopexin system, seen in many organisms such as Haemophilus 
influenzae.21,22 As in the ISD systems, this protein is secreted by the cell and binds free 
heme in the extracellular environment with one of the highest known affinities, having  Kd 
values estimated in the sub-picomolar range. When it binds heme the complex then binds 
to a cellular surface protein called HxuC (HemopeXin Utilization), which mediates its entry 
into the cell, followed by interaction with the HxuA and HxuB proteins that mediate heme 
release from hemopexin for uptake by cellular machinery.
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Once in the cell the concentration of heme must be carefully maintained, as free 
heme is cytotoxic.  It has been shown to cause a multitude of problems ranging from 
aggregation to the production of reactive oxygen species (ROS).13,23-25 The acquisition of 
6
    
Fig.	  1.3:	  Schematic	  representation	  of	  the	  Isd	  system	  heme	  transport	  components.	  
Heme	  transport	   and	  iron	  liberation	  is	   accomplished	  by	  the	  coordinated	  effort	  of	  
nine	  Isd	  proteins.	   IsdA,	   IsdB,	   IsdC,	   and	  IsdH	   (green)	   are	  covalently	   anchored	  to	  
the	   cell	   wall.	   IsdE	   and	   IsdF	   (blue)	   are	   the	   binding	   protein	   and	   permease	  
components	  of	  an	  ABC	  transporter,	  respectively.	  IsdE	  is	  shown	  in	  the	  heme-­‐bound	  
state	  prior	  to	   complexation	  with	  IsdF	   for	   transport.	   IsdD	   (blue)	  is	   a	  membrane	  
protein	   of	   unknown	   function.	   IsdG	   and	   IsdI	   are	   cytoplasmic	   heme-­‐degrading	  
enzymes.	  The	  ligand	  preferences	  for	  each	  member	  are	  illustrated	  as	  Hm	  (heme),	  
metHb	  (methemoglobin)	  and	  Hp	  (Haptoglobin–hemoglobin).	   For	  simplicity,	   IsdB	  
and	  IsdH	  are	  shown	  interacting	  with	  only	  one	  protein	  ligand,	  but	  in	  fact,	  IsdB	  also	  
binds	  Hp–Hb	  and	  IsdH	  also	  binds	  metHb.	  The	  predominant	  heme	  transfer	  path	  in	  
the	   Isd	   system	   is	   represented	   by	   arrows.	   Figure	   and	   legend	   reproduced	   from:	  
Jason	  C.	  Grigg,	  Georgia	  Ukpabi,	  Catherine	  F.M.	  Gaudin,	  and	  Michael	  E.P.	  Murphy	  in	  
the	  paper	   “Structural	  biology	  of	  heme	  binding	   in	  the	  Staphylococcus	  aureus	   ISD	  
system”	  Journal	  of	  Inorganic	  Biochemisty,	  Volume	  104,	  Issue	  3,	  2010.	  341-­‐348.12
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heme must be kept in check by the degradation or sequestration of heme. Degradation is 
predominantly carried out by the Heme-oxygenase protein.2 This protein consumes a 
molecule of NADH to convert heme into biliverdin, which is eventually converted to 
glucouronate and can be easily exported as waste. Cellular proteins such as ferritin can 
bind up the free Fe left over from this process. Though this method is the most common, 
certain organisms have been shown to circumvent it.26
1.1.5: Heme-Protein Assembly
After heme has been acquired and transported into the cell, holoproteins must 
assemble and attain a functional state. Little is known about spontaneous in vivo protein 
assembly. It is difficult to monitor these processes due to the many factors brought on by 
the complicated nature of a living  cell. It is not possible, with the current level of 
technology, to monitor a single protein such as myoglobin from the initial translation steps 
through heme assembly. Furthermore, genetic mutations required to either halt the 
processes or attach tags to monitor the protein throughout various stages may interfere with 
the function, inhibiting the protein’s normal activities and interactions. 
 Assembly can be monitored in complex systems, however. If a protein requires 
multiple chaperones to aid in folding  and heme association, knocking  out the chaperones 
pauses the process at a specific step. The most relevant work examining  heme proteins is 
not with soluble hemoproteins, but membrane bound ones. Cytochrome b6f was examined 
in  vivo with the aim of determining its assembly process. Kuras, Wollman et. al. were able 
to elucidate a genetic pathway that regulated the binding  of heme B to this complex (Figure 
1.4).27 In the C. reinhardtii organism, there are nuclear genes called CCB genes 
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(construction cytochrome B) that are known to control c-type assembly, however they 
appear to be implicated in the b-type assembly with the b6f complex. When these proteins 
are rendered non-functional, the cells appear to have the same phenotype as the b6f 
complex with its heme-binding  site removed. Similarly, in yeast, the bc1 complex requires 
the Cbp protein system to assemble.21 
It is unclear what the mechanism of this process is in both cases. The work done 
has only been at the genetic level as more direct biochemical observation is not possible. 
Based on structural and in vitro data, the proteins are thought to assemble with heme 
without any assistance. Proteins are needed to deliver heme but not directly insert it. 
Currently it is thought that the heme is sequestered until the protein is able to accept it, 
though it is unknown where.11  
8
    
Figure	   1.4:	   Schematic	   pathway	   of	   the	   conversion	   of	   apocytochrome	   to	  
holocytochrome	  b6	  and	  patterns	  after	  urea/SDS-­‐PAGE.	  A,	  membrane	  integration	  
occurs	  even	  in	  absence	  of	  heme	  association.	  B,	   there	  is	   formation	  of	  a	  bl	  heme-­‐
dependent	   intermediate,	   which	   can	   be	   prevented	   by	   heme	   depletion	  
(gabaculine	  treatment).	  C,	  Ccb1–Ccb4	  encoded	  nuclear	  factors	  are	  necessary	  for	  
the	  production	  of	  the	  holo-­‐form	  showing	  both	  bh	   heme	  binding	  and	  bl	  binding.	  
D,	  holocytochrome	  b6accumulates	  in	  a	  protease-­‐resistant	  form,	  upon	  association	  
with	  the	  other	  b6f	  subunits.	  Figure	  and	  legend	  reproduced	  from:	  Richard	  Kuras,	  
Catherine	  de	  Vitry,	  Yves	  Choquet,	   Jacqueline	  Girard-­‐Bascou,	  Duane	  Culler,	  Sylvie	  
Buschlen,	   Sabeeha	  Merchant,	   and	  Francis-­‐Andre	  Wollman,	   “Molecular	   Genetic	  
Identieication	   of	   a	   Pathway	   for	   Heme	   Binding	   to	   Cytochrome	   b6”	   Journal	   of	  
Biological	  Chemistry,	  Vol	  272,	  No.	  51,	  1997,	  pp.	  32427-­‐32435.20
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Prokaryotic systems have likewise been examined though not much more is known. 
One clear difference here is that heme assembly is thought to be a spontaneous process 
requiring no exterior proteins. Palombo and Daley show have worked out the process of 
the, cytochrome bo3 protein of E. coli (complex IV of the electron transport chain) 
providing  a mechanism for how this protein comes together.28 Subunit I must associate 
with II and III before heme can bind. In vitro experiments show that in the apo form 
subunit I binds heme with low affinity, and when these three subunits are together the 
affinity increases significantly. Heme-binding and additional conformational changes 
allows subunit II to associate making  a fully functional protein. It is still unknown, 
however, where the heme originates and the mechanism by which it is delivered to the 
proteins.  
 In vitro experiments have been done examining the affinity of heme to natural 
proteins. The tetrapyrrole ring  of heme is itself very hydrophobic and providing  a watertight 
pocket minimizes interactions with the aqueous solvent.29-31 In addition to providing  a 
hydrophobic pocket, the protein provides coordination bond(s) to the central metal. 
Typically this is a histidine residue, although cysteine, and methionine are known to ligate 
as well.32,33 These two factors are prevalent throughout many types of folds in nature. 
Globin and hemopexin folds are amongst the best known and both share a large amount of 
hydrophobicity in their binding  pockets. Interestingly many hydrophobic residues serve an 
additional purpose. Aromatic residues such as tryptophan and phenylalanine, in addition 
to generating  a water-tight pocket, also provide pi-stacking  interactions increasing  the 
affinity through this added stabilization.
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The structure of the heme-binding  cavity is critical to the protein not just for 
function but in many cases folding  as well. Myoglobin relies on heme for its folding 
process leading  to a final rigid structure. The importance of heme ligation is evidenced by 
the fact that the PDB has no published X-ray or NMR structures of myoglobin without 
heme or a heme-analogue present.34,35 Cytochrome b562 and b5 for example, have 
unfolded sections that gain a large amount of rigidity upon heme binding.36,37
1.1.6: Oxidation Reduction Midpoint Potential
 The many different oxidoreductase functions share a common aspect: Electron 
transfer. Monooxygenase proteins reduce oxygen in a controlled manner and cytochrome c 
peroxidase oxidizes cytochrome c. Depending on environmental factors the heme cofactor 
can either accept or donate electrons with a substrate.38 This is described by a 
thermodynamic parameter called the oxidation-reduction midpoint potential (Em). More 
specifically, this value is the potential of the environment where the oxidized and reduced 
10
    
Figure	   1.5:	   The	   reduction	  midpoint	   potential	   of	   free	   hemin,	   FePPIXCl,	   in	  aqueous	  
solution	  is	  shown	  for	  comparison.	  Reduction	  midpoint	  potential	  values	   correspond	  
to	   pH	   7-­‐8	   range.	   References	   for	   redox	   activity	   values,	   Figure,	   and	  Legend	  adapted	  
from:	   Julia	  M.	   Shifman,	   Brian	  R.	   Gibney,	  R.	   Eryl	   Sharp,	   and	  P.	   Leslie	  Dutton	  “Heme	  
Redox	   Control	   in	   de	   Novo	   Designed	   Four-­‐a-­‐Helix	   Bundle	   Proteins”	   Biochemistry,	  
Volume	  39,	  2000,	  14813-­‐21.41
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components of the half-cell reaction are equal. When two redox-active molecules are 
mixed together, electrons are spontaneously exchanged from the molecule with the lower 
Em to the one with the higher value. This is often exploited in nature; changing  the 
environment around individual cofactors creates a series of increasing Em values and a 
pathway for electrons to flow, like those seen in respiration and photosynthesis from above. 
7,39,40
 Nature has many ways of shifting  the midpoint potential of not only heme B, but 
the wide variety of cofactors seen in nature stabilizing  either the oxidized or reduced state 
(Figure 1.5). The most common heme variant, heme B, has an inherent midpoint potential 
of -200mV (Hemin in Figure 1.5)  in water but in natural oxidoreductases this is expanded 
to a very wide range, as low as -400mV in Cyt c3 and up  to +400mV in cytochrome b559.41 
One way is to attach different substituents to alter the electron density of the ring. Various 
changes to its tetrapyrrole ring  results in different heme types such as heme A, seen in 
cytochrome c oxidase (Em values of +200-350mV),42 and Heme-d1 in Nitrite reductase (Em 
of +234mV).43 In natural systems, any modification to the tetrapyrrole needs to be done in 
parallel to co-evolving  the binding  sites in order to accommodate the modified cofactors. It 
is this coevolution of the protein that complicates the study of the cofactors. Making  a 
certain change to one amino acid can have unforeseen effects shifting  the potential not by 
direct interactions but rather by weakening  the binding  site or changing  the water content 
of the local environment. 
Having different ligands to the heme Fe also changes its propensity for being 
oxidized or reduced.44,45 Histidine and methionine have been observed ligating  heme B 
and C46,47 and both have a significant effect on the Em. Methionine ligates more strongly to 
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ferrous iron as opposed to ferric, due to it being  softer according  to Hard Soft Acid Base 
theory.48 Sulfur increasing  the Em is not always the case, however. Thiolate ligation bonds, 
with their negative charge stabilize the ferric Fe, thereby suppressing  the midpoint 
reduction potential.
The axial iron ligands can also factor into the midpoint potential by changing  the 
spin state of the Fe at the heme center, a common trend seen in proteins such as 
cytochrome P450.3,49 In the low-spin state Fe (III)  is more stable, and the heme exhibits a 
lower midpoint potential. However, in the high-spin 5-coordinate state the midpoint 
potential increases. These midpoint shifts are important to the function of the protein. 
Cytochrome P450 is a well-known oxygenase that generates a potent oxidant capable of 
generating  radicals. In P450 enzymes the redox potential is part of the catalytic 
mechanism. In its resting  state, the heme is in a low spin 6-coordinate state. When 
substrate binds, a water ligand is removed and the heme converts to a 5-coordinate state 
with a corresponding  increase in the reduction potential. This shift is integral to the 
mechanism as it allows for a controlled reduction of the heme and the beginning  stages of 
the catalytic cycle. 
The environment however, is another common way of modulating  this value. The 
midpoint potential can be highly affected by water exposure as ferric heme is stabilized by 
hydrogen bonds in water with a Em value of -200mV (Figure 1.5).41 Water access is not the 
only environmental factor affecting the heme. Many amino acid residues are charged, 
either positively or negatively, at neutral pH. Having  these in the vicinity of the heme, or 
even coordinated to the Fe atom can cause significant shifts in the midpoint potential.50 
Having a lysine residue near the heme can cause a drastic increase in the midpoint 
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potential by destabilizing  the oxidized Fe (III)  state through coulombic interactions. 
Alternatively, having  a glutamate nearby, with a corresponding negative charge, will have 
the opposite effect of lowering  the Em by stabilizing  the Fe (III)  state. These types of amino 
acids are commonly used in natural proteins to cause shifts in the potential.51-53 
 Natural proteins often take advantage of these redox differences to control function. 
However, natural proteins often use a combination of these effects to modulate the 
potential. This complicates the study of how much one aspect of the environment affects 
the heme when in a protein. A single amino acid may have unseen or masked effects when 
mutated, or may affect the environment from a substantial distance away from the cofactor. 
This, along  with the initial heme assembly, have evolved over millennia, building in a 
significant tolerance to external environmental factors and genetic manipulation. These 
multiple utilities make for both a fascinating  yet complex system whose understanding 
remains thus far incomplete. Simplified systems are needed that can determine how the 
individual contributions affect the assembly and environmental factors of oxidoreductase 
functions.
1.2: Practical Approaches To The Study of Protein Assembly And Em Control
1.2.1: Evolutionary Complexity Hindering Study Of Assembly And Em Control
 Determining  the function and understanding  the natural role of an oxidoreductase 
protein is complicated at every step, starting from the earliest genetic stages. The protein is 
commonly removed from its natural context, and in doing  so there may be functions 
removed from the enzyme. 
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Most laboratories study the natural proteins directly in order to understand how the 
systems operate. They may mutate various residues and look for a change in the structure 
or function. However, by doing  this both the structure and function may be adversely 
affected in unforeseen ways. These changes may be direct and predicted, but can also have 
effects from sites remote to the active site. These effects could be from structural 
perturbations or gross misfolding  that changes other parameters of the protein (cofactor 
midpoint potential for example). Unintended consequences arise from the various 
pressures of evolution, which may have developed many complex and redundant features 
in natural proteins. These redundant mutations make the protein robust; however, they can 
inhibit their study by adding  unknown layers of complexity. For example, a series of 
mutations can end up compensating  for one another functionally so if an important amino 
acid is removed others can counterbalance it. Figure 1.6 depicts the relationship of 
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Figure	   1.6:	   Depiction	   of	   the	  
complexity	   brought	   on	   by	  
evolution.	  When	  a	  function	  is	  
present,	   such	   as	   crossing	   a	  
bridge	   (A),	   a	   nonfunctional	  
piece	   can	   be	   added	   (B).	   If	  
this	   nonfunctional	   piece	   is	  
rendered	   important	   (C)	   it	  
cannot	   be	   removed	   again.	  
This	   is	   a	   prime	   example	   of	  
M u l l e r ’ s	   r a t c h e t .	  
Al ternat ively,	   i f	   (B)	   is	  
naturally	   found	   and	   studied	  
it	   will	   be	   unclear	   which	   is	  
providing	   function,	   the	  
orange	   plank	   or	   the	   beige	  
stone.	  Removal	  of	  either	  still	  
allows	   for	   crossing	   of	   the	  
river,	   the	   intended	   function	  
of	  the	  bridge.	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redundancy in a simple cartoon where the function is crossing  a river.54 At first, it is 
possible to simply walk across on the stones to get from one side to the other (Fig. 1.6A). A 
mutation is then made wherein a plank is added which has little or no functional effect 
(1.6B). At this point, removing  either the plank or the middle stone would not impair the 
function of getting  across; if one were studying  this crossing removing  either of the two 
individually would not clearly demonstrate how these pieces contribute to getting across. 
This figure depicts another problem as well, one of evolved complexity. In 1.6A the 
function is simple, as it is in 1.6B as well, though slightly improved. However, when a 
mutation is made as in 1.6C, the middle stone is removed making  the plank critical to the 
function. Removing any piece would now completely wipe out the ability to cross the river. 
In natural proteins these types of mutations can occur greatly complicating the study of a 
natural function by adding  complexity that obfuscates a clear picture of what is going on. 
These are two simple examples that describe the inherent problems of directly studying 
natural proteins. There are many unforeseen changes that can be made originating  from 
evolution over the many millennia these proteins have existed.
1.2.2: Protein Design As A Tool for Understanding Natural Proteins
With protein design, the drawbacks of evolution are avoided as functions are 
engineered from basic chemical principles using amino acids. Functions can be directly 
studied and evolutionary complexity can be ignored as it is not part of the design process. 
However, there is not one single method of protein design, and different laboratories utilize 
varying approaches.
Despite the complexity of natural proteins, many laboratories utilize a method 
where minor mutations are made to well studied naturally occurring protein structures with 
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the aim of changing  their function. This method makes changes as small as point mutations 
in the hope that it alters the activity without affecting other attributes not directly related to 
function. This is beneficial as it allows for a fully functional binding  and/or active site to be 
formed, with the literature providing  guidance on which mutations can be tolerated. The 
change in function slightly circumvents the evolutionary complexity because the protein 
was not originally intended to perform this function so compensatory and redundant 
mutations have less of an effect. In addition, as the function is novel to this structure, many 
basic characterizations must be performed from scratch. One specific example of this is 
seen in myoglobin. Matsui, Morishima et. al. have made point mutations to both histidine 
residues in myoglobin changing  its function from an oxygen binding  protein to one with 
peroxidase activity.55 Simply changing  the electronic structure on the heme through the 
mutation of the ligating-his residue into a cys residue significantly changes the function. 
This has also been seen in the work of Yeung, Lu et. al..56 They also used myoglobin as a 
starting  point, and by making  mutations in the heme pocket they were able to convert the 
function from an oxygen binding protein to a nitric oxide reductase.  
Directed evolution is another approach made use of in the field of protein design.
57,58 With this method, a gene is randomized by methods such as error-prone PCR or 
mutator strains of bacteria. Many different versions are made creating a large library of 
genes, with some libraries getting as large as 1015 different mutations. These mutants are 
put through a high-throughput screen and proteins that have attained the desired target are 
examined to determine what residues they now have and how they factor into the desired 
function. This method works backward from the previous methodology, it does not involve 
a consideration of what steps are required before mutagenesis is done. Instead it keeps 
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randomly evolving  a gene such that it becomes more and more functional, and then the 
sequence and structure are examined to determine what amino acids are involved, and 
how the protein operates. This method has been very successful at a variety of structural 
functional and topological changes, modifying  proteins to have new quaternary structures, 
functions, and midpoint potentials.59 This method is primarily limited by the size of the 
library, which in turn is limited by the assay size. As assays get more sophisticated the 
potential for this field will grow. This technique has incredible potential, able to start with 
even the simplest proteins, in some cases using  only seven amino acids, and come out with 
complex functions. 
 A third common method used is computational design.60,61 In this method a 
protein is modeled with the aid of various computational tools, energetic minimization and 
Rosetta are common examples. In enzymatic designs, the proteins are constructed based 
around stabilizing  the transition state or binding  a specific cofactor.62,63 The computer is 
able to generate energy-minimized structures that would perform this action thereby 
generating  a new design. There are two methods a computer can use to do this.  First, the 
program can scan the library of known structures to find an appropriate scaffold and 
modify it as mentioned above. This has many of the advantages as site directed 
mutagenesis, but with the advantage of having a computer minimize the energies involved, 
thereby optimizing the intended function.  The second method of design is to have the 
computer itself build a structure de novo. This is obviously much more computationally 
taxing  as a variety of factors must be taken into account and energy minimization steps 
must be done frequently. As a consequence, these two methods are often combined. A 
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computer will scan the PDB and use various pieces of specific proteins to compile the best 
structure it can compute. 
 A fourth design approach makes use of simplified structures constructed from 
chemical principles. Named the maquette approach, it is much like the site-directed 
mutagenesis, but with one key difference, it starts with a simple scaffold protein that has no 
natural counterpart, not a natural protein. Due to its simplicity, every amino acid can be 
structurally and functionally accounted for. When changes are made to this protein the 
gain and or loss of a function can be readily assessed.64 This approach works as follows: 
starting  off with a simple scaffold protein whose sole function is to fold, and knowing  the 
function desired, minor modifications to the scaffold can be made with the aim of building 
in the goal. As these mutations are made in discrete steps and the scaffold is well defined, 
each mutation’s effect can be directly characterized. If unintended consequences arise from 
a change, we can either go back to the previous design or continue on noting  how the 
protein was affected in the current step. There is no mimicry; rather changes are chosen 
based on the underlying  chemistry of the intended function. Cofactor-binding  sites from 
natural proteins are not imported directly; rather they are examined and the chemical 
bonds made to heme or other cofactors are engineered into the new constructs. For 
example heme ligates to histidine residues in a hydrophobic core. The myoglobin-binding 
site sequence was not imported directly or mimicked, rather, to the hydrophobic core 
already part of the protein, two his residues were incorporated, achieving  a sub-
micromolar Kd value.65
 
1.2.3: Measuring The Em Value
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 The diversity of heme functions is strongly influenced by the midpoint potential. As 
such, the ability to describe how the protein environment is able to control this parameter 
is amongst the most important aspects of understanding  and reproducing  the variety of 
oxidoreductase functions. In both natural and synthetic systems a clear means of obtaining 
this value and being able to observe how mutations have affected it is crucial. The 
following  section describes a straightforward method applying chemical concepts to the 
study of protein electrochemistry. 
 Below is a description how electron transfer is measured and the underlying 
concepts. A more in depth discussion of these concepts can be found in the paper by P. 
Leslie Dutton.66 The midpoint potential is a thermodynamic parameter describing electron 
transfer, as such it can be directly related to Gibbs free energy through the following 
equation:
∆G = -zF∆E
where ∆G is the Gibbs free energy, z is the number of electrons involved in the redox half 
cell, F is Faraday’s constant (96,493 J/V), and ∆E is the difference in reduction potential 
between the two half-cell components of the reaction. This is easily coupled to the other 
free energy equation:
∆G = ∆G˚ -RTln(Keq)
where R is the gas constant, T is the temperature in Kelvin and Keq is the eqilibrium 
constant between reactants A and B. In this experiment, the equilibrium is between the 
oxidized and reduced species. The ratio of [reduced]/[oxidized]. ∆G˚ is the free energy 
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under standard unit conditions. Combining  these two equations yields the following  Nernst 
equation:
Ecell = !E +  
RT
zF
ln [A-Red][B-Ox][A-Ox][B-Red]
 
where ∆E˚ = (E˚A – E˚B) is the difference in standard potential between A and B. The point 
where the standard reduction potential Ecell is equal to the ∆E˚ is the midpoint potential of 
the redox pair being measured.
 There is no absolute value for a Em value so a scale must be defined. In the literature 
the standard hydrogen electrode (SHE)  scale is commonly used. This scale is based on the 
equilibrium between H2 and 2H+ + 2e-. This can take the place of component A in the 
above equation reducing it to the following:
Eh = EB +  
RT
zF
ln [B-Red][B-Ox]
Where Eh is the potential of the environment measured with the SHE. Given this, at 
equilibrium between A-Red and A-Ox, Eh is equal to E˚A which is defined as the midpoint 
potential for the B-component half cell.  
 Redox reactions are not always independent of pH and the [H+] must be factored 
into the equation above. In the case where the electron loss is coupled to proton loss
Red-H = Ox + H+ + e-    
The Nernst equation can be rewritten as such
Eh = EB +  
RT
zF
ln [Red-H][Ox][H+]
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Which can be further expanded to
Eh = EB +  - (0.06 x pH) 
RT
zF
ln [Red-H][Ox]
From this it is clear that the midpoint will change as a function of pH, 60mV for every pH 
unit under normal conditions. This can be a useful diagnostic tool, uncovering potential 
structural or electrochemical changes the protein undergoes as a function of redox state or 
pH. This relationship, because it is based in equilibrium, must be reversible. If re-oxidation 
of a reduced cofactor does not share the 
same potential at the same conditions it is 
indicative of some perturbation as well.37
 The method of Dutton et. al. is the 
most straightforward method of observing 
this value. By using a specially designed 
cuvette (Figure 1.7)  we are able to 
monitor both the UV/Vis spectra while at 
the same time monitoring  the potential of 
the environment.  The UV/Vis spectra 
allow for a direct observation of the 
concentration of each redox state, which 
can be coupled to the electrode reading. 
The use of spectra also make clear any 
changes to the system not associated with 
reduction such as free cofactor, or other 
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Figure	  1.7:	   Spectrophotometric	   cuvette	   for	  
redox	   potentiometric	   titrations	   at	   ambient	  
temperatures.	   Figure	   reproduced	   from	  
Dutton	  P.L.	  Methods	  of	  Enzymology.	  Vol.	  54,	  
1978,	  pp	  411. 37
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side redox reactions. 
 This method will be used throughout this work, and all numbers are relative to the 
Standard Hydrogen electrode (unless otherwise noted). 
1.3: Goals Of This Thesis
 The work detailed in this thesis deals with the effect of the protein on the assembly 
and control over the heme Em, two aspects that play a significant role in function.  I aim to 
uncover the physical chemical principles that underlie both of these processes and clearly 
demonstrate them in a simple protein system.   
Based on the goals of this thesis, the maquette approach is the best suited to answer 
the questions compared to other design procedures. The benefit of maquettes comes from 
the simple scaffold unburdened by evolutionary complexity. The physical chemistry of a 
certain process is more clearly demonstrated as a single change does not have allosteric or 
long-range effects that cannot be explained. The simple scaffold has does not have any 
overlapping amino acid functions or irreducible complexity seen in a natural proteins. 
Each amino acid can be directly traced back to the chemical principles underlying  their 
role in the sequence. Adding  to that simplicity is the rigorous characterization these 
maquette proteins are subject to for every mutation.
Through the efforts of this thesis, a better understanding of oxidoreductases 
becomes clear. The physical chemistry that underlies the assembly kinetics of these proteins 
is investigated along  with the midpoint control. These are two critical aspects of 
oxidoreductase function that are poorly understood in natural proteins.
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Chapter 2: Maquette Development and History 
2.1: What Is A Maquette?
As mentioned in the introduction we aim to use maquettes to learn about a protein 
fold or function by recreating it from the most basic chemical principles in a simple 
scaffold. This can only be done if the scaffold itself is well understood such that the role of 
each amino acid is characterized. The simple scaffold we use in this work is a 4-helix 
bundle, initially developed by Regan and Degrado in 1989.1 
 These bundles, from the earliest Degrado variant to the most recent positive variant, 
all have some basic attributes in common. First is the structure. All of the maquettes are 4-
α-helix bundles. They achieve this state by binary patterning, the positioning  of their 
26
     
     
Figure	  2.1:	  Demonstration	  of	  binary	  patterning	  in	  a	  simple	  diagrammatic	   cartoon.	  
Blue	   color	   represents	   positively	   charged	   residues,	   red	   negatively	   charged	   and	  
purple	  hydrophobic.	  Arranging	  these	  residues,	  based	  on	  their	  properties,	  as	  shown	  
allows	  for	  the	  spontaneous	  formation	  of	  a	  four	  alpha-­‐helix	  bundle	  in	  solution.	  The	  
nonpolar	  residues	  are	  buried,	  and	  the	  charged	  residues	  form	  salt	  bridges	  along	  the	  
outside	  of	  the	  helices.	  Shown	  here	  is	  a	  single	  helix	  (left),	  that	  can	  oligomerize	  and	  
assume	  two	  different	  topologies:	  syn	  (middle),	  and	  anti	  (right).	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positive, negative, and hydrophobic charges to maximize helical propensity and drive the 
formation of the bundle architecture seen all throughout maquettes in literature (Figure 
2.1). From the original three amino-acid helix (Sequence Appendix) the sequence has been 
altered many times which will be touched on below, however a more thorough review can 
be found in Lichtenstein et. al..2  
2.1.1: History Of Maquettes
 The first maquette created was a basic 4-α-helix bundle introduced by DeGrado 
and Regan. This was both the original and the simplest protein seen being  comprised of 
only 3  amino acid types. Its design was solely aimed at assembling  into a tetrameric four-
helix bundle with no further biologically relevant function. Its simplicity lead to it 
becoming the scaffold for future designs.
In order to increase the functional abilities of the protein carefully considered 
mutations were introduced. Most importantly histidine residues were added buried in the 
protein core in order for heme to bind and cysteines were added in order for the tetramer 
to link functionally creating  a dimer of dimers. This protein, named H10H24 was able to 
bind four heme B cofactors and all of them had discernable midpoint potentials and Kd 
values.3 This protein was later changed into H10A24, replacing  one of the histidine 
residues per helix with alanines residues.4 With these mutations each dimer unit can only 
bind one heme, making electrochemical and affinity characterization less complicated.
The H10H24 protein was subjected to structural studies as well.5 Huang  et. al. 
were able to use this protein as a scaffold to generate a protein from which a crystal 
structure was obtained. This provided structural information, useful for both the current 
designs and as a guide for future variants (BB, Sequence Appendix).
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In the crystal structure the protein dimers were stably in an anti conformation. This 
was exploited to create a new variant. No longer four single helices, this new protein was 
dimer of two helix-loop-helix motifs. This structural change revealed many possibilities, as 
the symmetry of the protein was now reduced from four identical helices to two identical 
helix-loop-helix motifs.6,7 Heme-binding  site knockouts were possible and the sequence 
could be better dispersed for NMR. This protein was further modified to include a disulfide 
bond covalently linking the dimers together. This formed a structure colloquially referred to 
as a candelabra, noted for its resemblance to the tool used to hold candles. With this 
protein, previous members of the laboratory were able to observe an oxyferrous state, the 
first example in a designed protein.8
This candelabra was converted into a true monomer by linking  the two-dimer units 
with a peptide chain comprised of glycine residues. This new protein, named the “Single 
Chain” has the same sequence and orientation of helices as the candelabra however there 
is less conformational freedom at the candle end. This new change also makes the 
symmetry even lower, as the entire sequence can be expressed as a single gene, whereas in 
the candelabra it was expressed as two dimers that were disulfide-linked.9 
Though this appears to be a simple change converting  a dimer into a monomer, it 
has much more significant effects. This change reduces the symmetry of the protein, a 
major hindrance to new functions. Binding  sites can be designed that incorporate dipoles 
and other uneven attributes not possible when the amino acids on either side are identical. 
These changes have lead to the creation of single histidine binding  sites, which can 
discriminate between Fe and Zn tetrapyrrole cofactors. This confers site specificity in 
maquettes and can also be used to incorporate different ligations not possible before. 
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2.2: The Current Generation Of Maquettes And Their Attributes
The single chain monomer shows a high degree of thermal stability and tolerance 
to sequence changes, both in the core and the surface.
The high α-helical content of these proteins makes circular dichroism a useful tool 
for determining  the stability of these maquettes.9,10 Figure 2.2 shows the temperature melts 
for the single chain protein as well as variants whose sequences have been altered both in 
the core, and on the surface. The changes allow for a high level of control over the Tm of 
the protein. Core packing  interactions can be changed to increase the stability of the apo 
state, as can surface charges to generate more salt bridges. NMR can give information on 
the tertiary structure of the protein in many ways complimentary to CD. It shows stability 
changes in the form of increased tertiary structure. The single chain for example gains a 
significant amount of structure upon heme addition, depicted as shifts and clarity of NMR 
peaks (Figure 2.3). This structure is brought on by the tethering  effect of the heme when it 
forms coordination bonds to the histidine residues on each helix. These coordination bonds 
also reduce the ability of the helices to rotate, further increasing their structural rigidity.
An important feature of all maquettes, from the earliest up to the current single 
chain, is heme binding. Previous work by Gibney et. al. has shown where in the sequence 
histidine residues can best be placed to maximize the heme affinity.4 The A-position of a 
standard helical wheel is important as it allows for the heme to be buried in a hydrophobic 
core. This has been maintained throughout all heme-binding  maquette variants, which has 
lead to sub-nanomolar affinities (Figure 2.4). This is an important result, ensuring that not 
only are the proteins stable when mutated, but heme binding can be readily monitored and 
adverse mutations can be easily identified.
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Figure	   2.2:	   Thermal	   denaturation	   of	   α-­‐helical	   content	   monitored	   as	   a	   loss	   of	  
circular	  dichroism	  at	  222	  nm.	  (A)	  Tm	   of	  the	  apo	  maquette	  increases	  from	  37	  to	  55	  
and	   95	   °C	   as	   the	   Histidines	   (black)	   are	   replaced	   by	   Alanines	   (blue)	   and	  
Phenylalanines	  (red),	   respectively.	  (B)	  The	  impact	  of	  heme	  binding	  on	  the	  thermal	  
stability	  of	  the	  helices	   is	  shown.	  Addition	  of	  one	  heme	  to	  Single	  chain	  reveals	  two	  
transitions	   at	   38	  and	  72	  °C	   (blue).	   	   Similarly,	   binding	  one	  heme	  to	   a	  single-­‐heme	  
binding	   maquette	  has	   two	   separate	   transitions	   at	   39	   and	   75	   °C.	   Upon	   adding	   2	  
hemes	   to	   the	   single	   chain,	   there	   is	   a	   single	   Tm	   transition	   at	   72	  °C,	   a	  35	  degrees	  
increase	   compared	   to	   the	   single	   chain	   apo	   maquette.	   	   All	   CD	   experiments	  were	  
performed	  with	  20	  µM	  protein	  in	  20	  mM	  CHES	  at	  pH	  9	  with	  150	  mM	  KCl.	   	  The	  CD	  
signal	   amplitude	   is	   normalized	   to	   1	  at	   5	  °C.	   Figure	   and	  Legend	  reproduced	   from	  
Farid,	  Kodali,	  Solomon	  et.	  al..	  Nature	  Chem.	  Biol.	  2013:	  Submitted9	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2.3: Potential Of Maquettes Past The Scope Of This Work
 Though not part of the scope of this work, it bears mentioning  that the maquette 
platform can be used to study more than just heme B cofactors. It has in the past been 
shown to allow for c-type heme maturation, covalently attaching a heme to the protein 
allowing for massive changes in the protein to not affect where the heme is or whether or 
not it is bound. Maquettes have also been used to study non-heme organic cofactors such 
as Flavins. Sharp and Farid have both shown flavin attachment coupled to light activated 
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Figure	  2.3:	  750	  MHz	   15N-­‐HSQC	   showing	  changes	  in	  NMR	  spectral	  dispersion	  upon	  
heme	  binding.	   Similar	   results	   are	   seen	   for	   the	  homo-­‐dimer	   candelabra	  (top)	  and	  
the	  single	   chain	   version	   Single	  chain	   (bottom).	   	   In	  the	   absence	   of	   cofactor,	   NMR	  
resonances	   are	   relatively	  undispersed	  (left	   column).	   	   Addition	   of	   one	   equivalent	  
of	  Fe(III)	  protoporphyrin	  IX	  (center	   column)	   induces	   partial	  dispersion,	  indicative	  
of	   stable	   structure.	   	   Addition	   of	   a	   second	   equivalent	   of	   heme	   (right	   column)	  
induces	   further	   structuring.	   NMR	   of	   candelabra	   was	   performed	   with	   350	   µM	  
protein	  in	  25	  mM	  KH2PO4,	  pH	   6.6	  at	  18	  °C.	   	   NMR	  of	   Single	  chain	  was	  performed	  
with	  200	  µM	  protein	  in	  50	  mM	  KH2PO4,	   50	  mM	  KCl,	   pH	   7.9,	   at	   25	   °C.	  Data	  from	  
Farid,	  Kodali,	  Solomon	  et.	  al..	  Nature	  Chem.	  Biol.	  2013:	  Submitted9
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electron transfer in a maquette 
platform.9,11 Quinone has also 
been attached covalently to the 
m a q u e t t e . 1 2 Th e w o r k o f 
Lichtenstein et al have developed 
a amino acid cofactor which can 
be easily incorporated into a 
maquette backbone with simple 
Merrifield chemistry. This has 
advantages over the cofactor work 
relying  on a disulfide bond, as the 
attachment to the protein is not 
succeptible to redox changes. 
 These various cofactor attachments have allowed for a lot of functions to be studied 
in maquettes. Flavin coupled with heme has been shown by sharp and Farid to be capable 
of light induced electron transfer. The benefit to doing  this in maquettes is that they allow 
for the control over positions in the protein. Distances can be adjusted to control specific 
electron transfer rates based on established guidelines. Oxygen binding  has also been 
described in this system. Maquettes, like certain natural proteins in the globin family, are 
able to exclude water from the protein core such that an oxyferrous state is stabilized.9
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Figure	  2.4:	  Kd	   titration	  data	  for	  the	  single	  chain	  
protein	  (at	   6nM),	   This	   experiment	   was	   carried	  
out	   at	   room	   temperature	   in	   20mM	   CHES	  
150mM	  KCl	   buffer	  pH	   9.	   Kd	   value	   calculated	  as	  
less	  than	  2nM,	  listed	  in	  Table	  3.1.
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
0 2 4 6 8 10
Ab
s 
(4
12
-7
50
)n
m
Equivalents Heme Added
33
 (3) Robertson, D. E.; Farid, R. S.; Moser, C. C.; Urbauer, J. L.; Mulholland, S. E.; 
Pidikiti, R.; Lear, J. D.; Wand, A. J.; Degrado, W. F.; Dutton, P. L. Nature 1994, 368, 425.
 (4) Gibney, B. R.; Dutton, P. L. Protein Sci 1999, 8, 1888.
 (5) Huang, S. S.; Gibney, B. R.; Stayrook, S. E.; Dutton, P. L.; Lewis, M. J Mol 
Biol 2003, 326, 1219.
 (6) Huang, S. S.; Koder, R. L.; Lewis, M.; Wand, A. J.; Dutton, P. L. P Natl Acad 
Sci USA 2004, 101, 5536.
 (7) Koder, R. L.; Valentine, K. G.; Cerda, J.; Noy, D.; Smith, K. M.; Wand, A. J.; 
Dutton, P. L. J Am Chem Soc 2006, 128, 14450.
 (8) Koder, R. L.; Anderson, J. L. R.; Solomon, L. A.; Reddy, K. S.; Moser, C. C.; 
Dutton, P. L. Nature 2009, 458, 305.
 (9) Tammer A. Farid, G. K., Lee A. Solomon, Bruce R. Lichtenstein, Molly M. 
Sheehan, Bryan A. Fry, Chris Bialas, Nathan M. Ennist, Jessica A. Siedlecki, Zhenyu Zhao,  
Matthew A. Stetz, Kathleen G. Valentine, J. L. Ross Anderson, Bohdana M. Discher, A. 
Joshua Wand, Christopher C. Moser and P. Leslie Dutton1 In Nat Chem Biol 2013; Vol. 
Submitted.
 (10) Gibney, B. R.; Rabanal, F.; Reddy, K. S.; Dutton, P. L. Biochemistry-Us 1998, 
37, 4635.
 (11) Sharp, R. E.; Moser, C. C.; Rabanal, F.; Dutton, P. L. P Natl Acad Sci USA 
1998, 95, 10465.
(12)Lichtenstein, B. R.; Cerda, J. F.; Koder, R. L.; Dutton, P. L. Chem Commun
2009, 168.
33
     
     
34
Chapter 3: The Protein Influence On Holoprotein Assembly Kinetics 
3.1: Introduction
The main goal of this section is to uncover the physical chemistry of heme and 
protein assembly. Throughout the literature, the thermodynamics have been investigated 
significantly more than the kinetics.1 Despite how much is known about the 
thermodynamics of heme-protein assembly, the kinetics generally remain poorly 
understood.  Hargrove et. al. explored the effect of mutating  various residues in the heme 
cavity of myoglobin looking for a change in binding  rate of heme B, demonstrating how 
individual residues do not contribute significantly to this process.2 Various groups have 
looked at the binding  rates of proteins such as cyt b5 and cytochrome c peroxidase but still 
no formal set of engineering guidelines have emerged.3,4 
In this chapter, I present the study of heme-protein assembly kinetics using  protein 
maquettes and the natural protein Cytochrome b562. These proteins are all 4-α-helix 
bundles with nanomolar heme B affinities. The low Kd values allow me to focus squarely 
on the assembly mechanism, and characterize the steps involved in holoprotein 
construction.
This work will illustrate how assembly kinetics can be incorporated into maquette 
designs. The barriers are clearly shown, and ways to circumvent them are explained. When 
these concepts are applied,  a designed protein capable of an assembly reaction  that rivals 
natural proteins can be generated. 
3.2: Kinetics Of Holoprotein Assembly 
3.2.1: Proteins Used For This Study
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Each protein in this paper is limited at a different stage of the process depending  on 
its structural characteristics (Scheme 3.1, Table 3.1). k1 presents protein pre-assembly, 
depicted as the coming  together of two dimers, though more generally referring to the 
protein accessing a structure suitable for heme-binding. The third rate, k3, is the partitioning 
step.  This rate constant represents the speed at which a cofactor moves from the solvent to 
the protein core.  k4, the final rate, is the ligation step, representing  the cofactor finding  the 
proper residue and forming  a coordination bond as well as the protein structurally 
conforming  to the presence of heme.  k2 depicts the cofactor deaggregation. This step 
pertains to heme or other cofactors being  in a soluble, monomeric and non-aggregated 
state freely available to associate with protein, this is the topic of chapter 4.
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Scheme	  3.1:	  Reaction	  scheme	  for	  the	  protein	  Tetrapyrrole	  binding	   reaction.	   	   k1	  
demonstrates	   the	  protein	   forming	   an	  appropriate	   binding	   site.	   Concurrently	   k2	  
illustrates	   the	  the	  cofactor	  also	  becoming	  able	  to	   assemble.	   	  k3	   then	  depicts	   the	  
rate	   of	   partitioning	   forming	   an	   unligated	   complex	   of	   the	   cofactor	   and	   protein,	  
where	   the	  heme	  is	   in	  the	  core	  but	  not	  bound.	  Finally,	   this	   complex	   einds	   its	   einal	  
conformation	  at	  a	  rate	  of	  k4	  leading	  to	  the	  einal	  protein.
36
Kd values for the structured homotetramer, and homodimer had to first be obtained 
as the rest have been obtained previously from the literature.9-11 Figure 3.1 shows these 
experiments. These experiments were performed as described in the methods section and 
were fitted as described in the methods section. All of these affinities are in the same 
general nanomolar range. The homodimer is an exception, it is unable to generate a Kd 
value, as, at the concentrations required for this assay, the protein is not dimerized in 
solution and thus not in a structurally associated state.
To explore the homodimer’s lack of apparent binding, a reverse titration was done. 
In this experiment, instead of heme being  added to a fixed amount of protein, the 
homodimer protein was added to a fixed amount of heme. Figure 3.1B shows this 
36
     
      
Table	  3.1:	  Protein	  topologies,	  structural	  states,	  heme	  B	  afeinities,	  and	  limiting	  rates	  
of	  the	  proteins	  used	  in	  this	  chapter.	  The	  topologies	  are	  depicted	  as	  cartoons	  of	  the	  
various	  designs.	  Helices	  are	  depicted	  as	  cylinders	  and	  loops	  as	  curves.	  Curves	  with	  
“SS”	  in	  the	  middle	  denote	  a	  disuleide	  bond	  linking	  loop	  sections	  together.	  Structure	  
in	   apo	   and	   holo	   states	   is	   based	   on	   NMR	   data:	   Structured	   Homotetramer	   and	  
Unstructured	   homotetramer,5	   Tethered	   Homodimer,6	   Single	   Chain,7	   and	   b562.8	  	  
Heme	  B	  afeinities	  for	  Unstructured	  Homotetramer,	  Tethered	  Homodimer	  and	  b562	  
were	  obtained	  from	  the	  literature.10-­‐12	  Single	  Chain,	  Structured	  Homotetramer	  and	  
Homodimer	  are	  from	  this	  work.	  
37
experiment. At low concentrations, there appears to be little binding, which begins to 
increase in slope, achieving  a maximum at 2µM. Below 2µM the protein is unable to hold 
its dimer form dissociating  into solution, whereas above 2µM it is able to form a sufficient 
binding site for the heme to assemble with. 
3.2.2: Kinetic Characterization Of The Proteins Used
The first step in examining  this kinetic mechanism was to determine the order of the 
reaction. This was done by rapidly mixing  a range of concentrations of protein with excess 
heme or an excess of the single chain protein with a range of concentrations of heme. In all 
of the following  assembly experiments assembled proteins were monitored by the shift in 
absorbance at the Soret band (Figure A3.1-3). As shown in figure 3.2 all but two of these 
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Figure	  3.1:	  Kd	  titration	  data	  for	  (A)	  the	  structured	  homotetramer	  (at	  50nM),	  and	  (B)	  
the	   homodimer	   (6µM	   heme).	   All	   experiments	   were	   carried	   out	   at	   room	  
temperature	   in	   20mM	   CHES	   150mM	  KCl	   buffer	   pH	   9.	   Structured	   homotetramer	  
titration	  was	  performed	  using	  a	  10cm	  path	  length	  cuvette.	  The	  homodimer	  was	  not	  
carried	   out	   in	   the	   same	   conditions	   as	   it	   is	   unable	   to	   bind	   heme	   at	   nM	  
concentrations.	   For	   this	  protein,	   the	  heme	   concentration	  was	   set	   at	   6µM,	   and	  the	  
protein	   was	   added	   in	   aliquots	   as	   depicted	   in	   (B).	   Kd	   value	   for	   structured	  
homotetramer	  is	  calculated	  as	  <2nM,	  listed	  in	  Table	  3.1.
38
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Figure	  3.2:	  Plots	   of	  rates	  versus	  concentration	  of	  the	  single	  chain	  protein	  (A),	   Cyt-­‐
b562	  (C),	   Structured	  homotetramer	  (D),	  Unstructured	  homotetramer	   (E),	   and	  the	  
Tethered	  homodimer	  (F).	  The	  rates	  were	  taken	  from	  the	  initial	  slope	  of	  the	  reaction	  
(eirst	  20msec.).	   All	   experiments	  were	   carried	  out	   at	   20˚C	   in	  20mM	  CHES	  150mM	  
KCl	  buffer	  pH	  9,	  heme	  at	   20µM.	   (B)	  Rates	  of	  heme	  vs	   concentration	  were	   carried	  
out	  with	  excess	  single	  chain	  protein,	  30µM,	  in	  20mM	  CHES	  150mM	  KCl	  buffer	  pH	  9	  
at	   20˚C.	   Rates	   for	   the	   single	   chain	   and	   heme	   were	   obtained	   on	   a	   eluorescence	  
stopped	  elow	  monitoring	  the	  change	  of	  emissions	  at	  350nm	  in	  the	  eirst	  20	  msec.
39
proteins follow standard second order behavior (1st order with respect to both reactants) 
increasing  in rate commensurate with concentration. Panel B shows that the heme itself is 
also first order in this reaction, increasing in rate commensurate with concentration. 
The tethered-homodimer and the homodimer require further explanation. The 
homodimer appears to have two distinct phases depending  on the concentration (Figure 
3.3). In the first twenty milliseconds of the reaction there is a noticeable burst phase for the 
three and four micromolar concentrations. This is most likely brought on by the tendency 
of the protein to be partially assembled in solution at these concentrations whereas below 
these concentrations, it behaves in a fashion more resembling  a monomeric structure. 
There is a slight burst phase in the two-micromolar trace however no noticeable one in the 
one-micromolar trace. Once the burst phase is over (approximately 20msec.) the kinetics 
appear to once again have standard first order kinetics within the error of the 
39
     
      
Figure	  3.3:	  (A)	  Absorbance	  at	  412nm	  for	  the	  homodimer	  protein	  over	  3.5	  seconds	  
tracking	  the	  assembly,	  and	  (B)	  rates	  as	   a	  function	  of	  concentration	  of	  protein.	  At	  
the	  initial	  20	  milliseconds	  of	  the	  reaction	  there	  is	  a	  short	  lived	  burst	  phase	  in	  the	  
2,	  3,	  and	  4µM	  traces	  but	  not	  in	  the	  1µM	  sample.	  Based	  on	  the	  afeinity	  data	  this	  is	  
due	   to	   the	  lack	  of	  associated	  monomers	   in	  solution.	  The	  rates	   in	  (B)	  follow	  eirst	  
order	  kinetics	   with	   respect	   to	   the	   protein	   above	   the	   1µM	  sample.	   All	   data	  was	  
collected	  at	  20˚C	  in	  20mM	  CHES	  150mM	  KCl	  buffer	  pH	  9.	  Heme	  at	  20µM
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measurements (Figure 3.3, Panel B). The tethered homodimer in contrast does not have a 
burst phase. Its kinetics are not first order with respect to the protein but appear to be ½ 
order, with the total reaction being 1.5 order overall.  
I next had to determine any differences in the rates of different binding sites. Of the 
six proteins tested, the homodimer, tethered homodimer, and the single chain have two 
heme-binding  sites. Both the unstructured and structured homotetramer proteins have two 
sites but one cannot be removed as any change to the sequence is bound to the four-fold 
symmetry of these maquettes. Cyt-b562 only has one binding  site. The single-chain protein 
and tethered homodimer were compared to each site knockout. In these proteins, either 
the 7 or 42 histidine was removed (Sequence Appendix). In the single-chain protein the 
removal of residues 7 and 42 yield one mono-his heme-binding  sites per bundle. Mono-
histidine sites have such a low affinity they can be ignored in this experiment. Figure 3.4 
shows the effect of these knockouts on the binding  kinetics. In the single-chain the rates 
between H7A (200msec) and H42A (159msec)  differ by approximately 40msec, sufficiently 
close to treat them as the same. The tethered homodimer mutant is not as simple. The 
standard variant and the H42 site knockout appear to have the same rate (halftime of 
250msec)  however, the H7 site knockout is approximately 3 times slower (halftime 
750msec). What this means is the H7 site potentially requires a pre-assembly step, one that 
the H42 sites does not. This pre-assembly is achieved upon heme binding to the H42 site 
thus explaining  why the variant with both sites achieves the same kinetics as the H7-
knockout. Moving forward, the effect of knocking out a binding  site can be ignored as 
when one site is not present the rate does not appear to be affected compared to both sites 
intact.  
40
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Finally, I had to determine the differences in binding  rate. The six variants and heme 
B  were rapidly mixed at 30˚C. Due to the bis-histidine ligation, heme bound to protein has 
an aborbance at 412nm far to the red of free heme (395nm). Figure 3.5 shows each protein 
has different kinetics spanning  a wide range of rates. The heme-binding  of the three fastest 
proteins, single-chain, b562, and tethered homodimer all had halftimes within 500 msec 
(rate constants of 3.04x105 M-1 s-1, 3.04x105 M-1 s-1, and 1.73x105 M-1 s-1 respectively, Table 
2). This contrasts with the three other proteins: homodimer, structured homotetramer, and 
unstructured homotetramer, which had much slower assembly rate constants (3.24x103 M-1 
s-1, 7.3x103 M-1 s-1, and 2.68x104 M-1 s-1 respectively Table 3.2). From this data one piece of 
41
     
      
Figure	  3.4:	  Rates	  for	  (A)	  the	  Tethered	  homodimer	  and	  its	  site	  knockout	  mutants.	  
The	  H42F	   and	  wild-­‐type	  variants	  share	  similar	  rates,	   but	   the	  H7F	  variant	  binds	  
heme	  much	  slower.	  This	  is	  likely	  due	  to	  a	  mild	  pre-­‐assembly	  reaction	  not	  present	  
in	  H42F	  or	  the	  “wild-­‐type	  variant”.	  (B)	  The	  single	  chain	  protein	  and	  its	  individual	  
site	   knockouts,	   unlike	  the	   tethered	  homodimer,	   all	   share	  the	  same	  kinetics	  with	  
halftimes	   differing	   by	   40	  msec..	   All	   data	   was	   collected	   at	   20˚C	   in	   20mM	  CHES	  
150mM	  KCl	  buffer	  pH	  9.
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information becomes immediately clear: proteins that are obligatory monomeric in 
solution are able to assemble faster than ones in which the four-helix bundle architecture is 
composed of separate 
pieces. This could be 
due to either having the 
dimers come together in 
solution or having  to 
rearrange them into a 
s u i t a b l e f o r m f o r 
assembly. The specific 
barriers and reasons for 
the unique kinetics 
were not clear from this 
data; another approach 
was needed.
3.2 .3 : Tempera tu re 
Dependen t K ine t i c 
Analysis
Temperature dependent kinetics were used to identify the specific barriers 
hindering  assembly. Figure 3.6 shows what is known as an Eyring  plot.12 This analysis uses 
the rate constants at various temperatures to explore the transition state. The underlying 
theory treats the transition state and the ground state reactants as being  in equilibrium. This 
mathematical expression generates pseudo free energy from the equilibrium, which can be 
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Figure	  3.5:	  Comparison	  of	  the	  binding	  rates	  of	  heme	  and	  
the	   various	   proteins	   used.	   The	   proteins	   that	   are	  
monomeric	   in	   solution	   achieve	   the	   fastest	   rate	   (single	  
chain,	  tethered	  homodimer,	  and	  b562)	  whereas	  removal	  of	  
the	  monomeric	   character	  substantially	  slows	  this	  process	  
(homodimer,	  unstructured	  homotetramer,	   and	  structured	  
homotetramer).	   All	   data	   was	   collected	   at	   30	   degrees	  
Celsius	   in	   20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9.	   All	  
proteins	  are	  at	  5µM,	  Heme	  is	  at	  10µM
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further broken down into pseudo enthalpic and entropic components. These give a 
valuable insight into how 
the transition state is 
energetically limited and 
can indicate how the 
r e a c t i o n i s l i m i t e d 
generally. 
The Eyr ing ana lys i s 
clearly demonstrated the 
barriers for each protein. 
I n t h e c a s e o f t h e 
structured homotetramer, 
a protein known to have 
a rigid apo structure,13 
heme assembly is the 
m o s t s e n s i t i v e t o 
temperature. This behavior is due to its high transition state enthalpy (17.9 kcal/mol), 
brought on by its tightly packed apo-core (Table 3.2, Figure 3.6).
This is contrasted with the unstructured homo-tetramer. The sequence of these two 
proteins  differs by four residues in each helix (I6L, F14L, H24A, and M31L; Sequence 
Appendix). These changes cause its structure to be unstructured on NMR timescales in both 
apo and holo states (Table 3.1). This dramatically increases the heme assembly rate by 
lowering  the transition state (TS) enthalpy to 11 kcal/mol (Table 3.2). The transition state 
43
     
      
Figure	   3.6:	   Eyring	   plot	   of	   the	   rates	   as	   a	   function	   of	  
temperature	   for	   the	   homodimer	   (blue),	   structured	  
homotetramer	   (black),	   unstructured	   homotetramer	  
(pink),	   tethered	   homodimer	   (red),	   single	   chain	   (green)	  
and	  Cyt	  b562.	   All	   rates	   were	   taken	   from	   initial	   slopes	   of	  
412nm	   absorbance	   converted	   into	   concentration	   of	  
holoprotein	  at	  various	  temperatures.	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entropy is higher (48.3 cal/mol-K), though does not impose a barrier as intense as the 
enthalpy.
 The homodimer assembly is very slow and appears to be independent of 
temperature, indicative of an entropically limited transition state, has a ∆H‡ of -1559 cal/
mol and ∆S‡ of 94 cal/mol-K (Table 3.2). Previous reports have often attributed this to 
active site rearrangments and other protein folding  reactions, which are possible here as 
well.14-16 However, the data do not make clear what exactly is happening.
The tethered-homodimer and homodimer are identical in sequence and function, 
except for a cysteine residue replacing a serine in the loop region (Sequence Appendix, 
Table 3.1).  This cysteine creates a disulfide bond between the two dimers, which makes 
the protein a monomer in solution. This seemingly minor change has a major effect on the 
rate decreasing the entropy to -53.44 cal/mol-K and increasing the enthalpy 8.73 kcal/mol 
(Table 3.2). These changes greatly increase the rate over the temperature range monitored 
and, since the entropy is no longer the major barrier, reinstates the temperature 
dependence seen with the other maquettes (Figure 3.6).
The single-chain protein shares the majority of its sequence with the tethered 
homodimer protein. The exception being  an amino acid loop  converting two dimers into a 
monomer (Sequence Appendix). Compared to the homodimer, this loop decreases the 
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Table	  3.2:	  Summary	  of	  rates	  and	  transition	  state	  parameters	  of	  the	  heme	  binding	  
reaction	  of	  the	  proteins	  used	  in	  this	  chapter.
Protein k at 30˚C (303K) ∆H‡ ∆S‡
  (M-1 s-1) (cal M-1) (cal M-1 K-1)
Structured Homotetramer 7.3x103 17.87x103 -28.85
Unstructured Homotetramer 2.68x104 11.20x103 -48.3
Homodimer 3.24x103 -1.56x103 -94.94
Tethered Homodimer 1.73x105 8.73x103 -53.44
Single Chain 3.04x105 10.62x103 -46.22
b562 3.04x105 11.53x103 -42.89
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entropic barrier to -46.22 cal/mol-K, and increases the enthalpy to 10.6 kcal/mol (Table 
3.2). These parameters combine to yield the fastest reaction rate constant of all the proteins 
in this work.  
Cytochrome b562 is unlike the other 5 designed maquettes in the sense that it is a 
natural protein present in E. coli thought to be involved in electron transfer.17 This protein 
binds heme at a rate apparently equal to the SC maquette, both having comparable 
transition state parameters and rate constants (Table 2). 
3.2.4: Analysis Of The Assembly Kinetics
The above data uncover differences in the rates, and kinetic limitations of the 6 
protein variants, and describes where in scheme 3.1 they are limited. Generally, the two 
major limiting  steps for the protein seem to be k1 and k3, no protein appears limited at the 
ligation step k4. Rate k1 can be described clearly by the data in figure 3.5, as the assembly 
rates vary significantly depending  on the oligomeric state of the protein, seen here with the 
monomeric proteins assembling  with the highest rate (Figure 3.5). Single-chain b562 and the 
tethered homodimer bind heme at the highest rate. These three proteins are all monomeric 
in solution. The other three proteins are all dimeric in solution, and bind heme at a much 
slower rate. For example, the homodimer protein does not have any designed interactions 
to promote monomeric character and is therefore unable to bind heme at an appreciable 
rate. The addition of either a disulfide bond or amino acid loop connection drastically 
improves the assembly rate, facilitating  the generation of a heme-binding pocket by either 
keeping  the individual helices of the protein close to one another, or limiting  its ability to 
rearrange in solution. Rearrangements have been seen before in maquettes, in the work on 
the H10S24 protein of Grosset et. al.,18  This protein had the ability to assume either a syn 
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or anti conformation depending  on the redox state of the heme. This entropic barrier would 
obviously slow the assembly rate as the protein would have to conformationally rearrange 
in order to form the binding  site for heme. Having  a linker, stopping the protein from 
rearranging, would lower this barrier and increase the rate as seen with the proteins here.
This behavior is similar to that of some natural proteins; for instance cytochrome b5 
consists of two domains, one of which binds heme.19 When it is in its apo form the heme-
binding  domain is unstructured, only folding  into its native state upon heme binding. The 
other domain, which acts analogously to our third loop  or disulfide bond linker, holds it 
together.  If this other domain were not present the heme-binding loops would be unable to 
conform to heme, as they would not be held near each other rendering the protein useless.
The core packing  of the protein is the other major barrier to the assembly rate. This 
enthalpic barrier is the result of having to break apart interior van der Waals interactions 
and water shell hydrogen bonds. An example of this is the structured homotetramer. This 
protein is known to have a rigid apo state brought on by core packing interactions and 
hydrogen bonds between histidine residues.9 In order for a heme to bind, these must first 
be broken which requires a significant amount of thermal energy slowing  the reaction. If 
these interactions are removed, and the apo structure is destabilized as with the 
unstructured homotetramer protein, the rate increases substantially. These two proteins 
share a high level of sequence overlap  (85% homology) differing  only in their core 
packing, yet the assembly rate constants differ by a factor of 3.7 (Table 2, Sequence 
Appendix). This barrier goes from being limited at k3 to being limited at k1.  
Based on the similarity in rate over the temperature range shown between single-
chain and b562, and their unrelated sequences it seems reasonable to suggest that the rate-
limiting  step is likely to be the availability of porphyrin in solution (k2 in scheme 3.1). 
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Heme as a cofactor when free in solution is well known to form soluble oligomers.20 
However, the protein is only able to bind monomers of heme, therefore the assembly is 
most likely limited by the monomer availability for these two proteins. 
  The variants with the fastest rate have in common a molten globular apo state, that 
upon heme binding, changes to a rigidly structured holo state. It seems likely that the apo 
state makes available many energetically equal microstates for the heme to bind as 
opposed to one specific binding  ready conformation. The proteins also have monomeric 
character. Being  in a single structure helps to lower the ∆S‡ by limiting  its ability to assume 
other topologies as well as keep pieces from dissociating. 
 
3.3: Proof Of A Partitioned Heme State
 Of the various states in the mechanism discussed above (Scheme 3.1), the only one 
that cannot be directly monitored in the course of a normal reaction is the partitioned state. 
In order to prove its existence we used a protein that resembles the single-chain, except for 
four mutations changing  the histidine residues to phenylalanine, the single-chain-F 
(Sequence Appendix). This allows for all of the steps to occur except for histidine ligation.
 In figure 3.7 we see that, upon combining  the histidine-less protein with heme 
cofactor in solution, there is a change in the spectra. The shoulder on the free heme spectra 
decreases while the peak at 400nm sharpens and increases a small amount. The spectra 
appear to be shifting to resemble more of heme in DMSO, a solvent where it is well known 
to not aggregate (Spectral Appendix: Figure A3.1). This data indicates that the heme in the 
protein core is monomeric and able to remain in that state.
To further observe this state and confirm its existence the absorbance was 
monitored again. However, in this experiment, rather than heme, which has a minor 
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spectral shift in the UV-Vis absorbance range, Zn-protoporphyrin IX (ZnPPIX) was used as it 
has a larger difference between 
its aggregate and partitioned 
states. In figure 3.8, we see a 
shift in the Soret band of the 
ZnPPIX over the course of 90 
minutes after addition to an 
aqueous solution of histidine-
less protein. This slow change is 
consistent with the breaking  up 
o f the aggrega tes as the 
porphyrin partitions into the 
protein core. It is not clear from 
this data whether the protein is 
directly interacting  with the 
porphyrin-aggregate, acting like a deaggregase, or just associating  with the small amount of 
free porphyrin in solution and shifting  the equilibrium. However, without the ability to 
ligate, the hydrophobic interactions appear strong enough to allow for some interactions 
between the two species that causes a spectral shift consistent with an increase in 
monomer concentration. 
 To once more prove that the protein was interacting  with the porphyrin and 
absorbance changes were not artifactual, I carried out a fluorescence titration on single 
chain, single chain-F, and a small peptide with the sequence WAGWA (Figure 3.9). 
WAGWA was chosen for its solubility. This experiment monitored a drop in the tryptophan 
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Figure	  3.7:	  Heme	  has	  a	  spectral	  shift	  when	  mixed	  
with	   a	   protein	   that	   has	   no	   histidine	   residues	  
(red)	  compared	   to	   free	   heme	   in	  solution	   (blue).	  
The	  green	   trace	   depicts	   the	   difference	   spectrum	  
of	   the	   other	   two	   (protein	   -­‐	   free).	   Work	   done	   in	  
CHES	  buffer	  pH	  9	  at	  room	  temperature
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fluorescence signal due to the presence of heme quenching  it. This only occurs when heme 
is near a tryptophan residue taking  part in an energy transfer reaction.  In this figure, we 
see an expected drop 
i n t r y p t o p h a n 
fluorescence as heme 
is added to the single-
chain protein. The 
sharp  drop in signal 
persists until the heme 
b ind ing  s i t e s a r e 
saturated at which 
point there i s no 
signal change.  The 
WAGWA peptide has 
no core into which to 
partition nor does it 
have any sort of binding site for the heme to associate.  The decrease in fluorescence in this 
case is due to the background absorbance of light by the heme and any collision based 
quenching that occurs in solution.  The third trace, single chain-F, has a quenching profile 
that is in between the two, indicating  that it has more heme associated with it than the 
WAGWA but not as much as the ligation-able single chain.  This can be explained by the 
heme partitioning into the protein core of single chain-F without being  held there tightly, 
thus dissociating.  
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Figure	   3.8:	   ZnPPIX	   associating	   with	   the	   single-­‐chain	  
hisitdine-­‐less	   protein.	   There	   is	   a	   noticeable	   spectral	   shift	  
between	  the	  starting	  spectra	  (red)	  and	  the	  spectra	  after	  90	  
minutes	   (blue).	   Data	   collected	   in	  20mM	  CHES	  150mM	  KCl	  
buffer	  pH	  9	  at	  room	  temperature.	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 The spectral changes in concert with the fluorescence titration demonstrate the 
presence of a state between that of the heme-ligated state and that of the heme-unbound 
state. The spectra begin to 
assume characteristics 
similar to that of heme in 
DMSO, wh ich i s i n 
a g r e e m e n t w i t h t h e 
l i t e r a t u r e a s n o n -
aggregated spectra.  These 
states form too quickly to 
have their kinetics traced 
in the s ingle chain, 
tethered homodimer, and 
b562 proteins. In order for 
this state to be observed it 
requires a protein that 
cannot ligate to heme 
w i t h a n y r e s i d u e s . 
Structured homotetramer 
is unable to retain its 
structure without the histidine residues in the core, as they are responsible for maintaining 
its structure in the apo state and the holo state therefore observing a heme-partitioned state 
is impossible. This state is also not observable in the homodimer protein as it requires the 
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Figure	  3.9:	   Fluorescence	   titration	  shows	   the	   quenching	  
of	   tryptophan	   when	   heme	   is	   added.	   The	   single	   chain	  
protein	  (red	  cirlces)	  loses	  all	  of	  its	  eluorescence	  intenisty	  
at	  2	  equivalents	  of	  heme,	  while	  the	  free	  WAGWA	  peptide	  
(green	  diamonds)	   loses	   only	  half	  at	   this	   point.	  The	  His-­‐
less	   protein	   (blue	   squares)	   loses	   an	   intermediate	  
amount	  indicating	  that,	  despite	  its	   low	  afeinity,	   heme	  is	  
partitioned	   in	   or	   held	   near	   the	   Trp	   residues.	   Data	  
collected	  in	  20mM	  CHES	  150mM	  KCl	  pH	  9	  buffer	  at	  room	  
temperature.	   Excitation:	   280nm,	   Emission	   at	   350nm.	  
Emissons	  normalized	  to	  the	  signal	  at	  0	  eq.	  heme	  added
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heme as a structural piece to form the binding  site. Without the histidine residues this 
protein cannot dimerize much less form a cavity for the heme to partition into.  
3.4: Conclusions
The different temperature response behaviors can be used to probe which aspect of 
the reaction is rate limiting for each protein and make clear what alterations can be made 
to speed up the assembly rate.  Using the data above as the basis of a model, it is possible 
to compare one protein’s heme binding rate over a range of temperatures and uncover the 
limiting  step of assembly. This will be a useful tool for protein designers going  forward, 
helping  them to explain why a particular design would have a slower assembly rate than 
another.
 For a maximally fast rate two features must be at the core of the design: 
Monomeric character and molten globularity of the apo-form. The monomeric character 
significantly lowers the entropy of the transition state, which manifests as either diffusional 
assembly of dimers or topological rearrangements. This is most clearly seen in k1 and has 
been observed in previous maquette designs. 
A molten globular apo-core can considerably increase the rate by lowering  the 
enthalpy. This concept reduces the ∆H‡ by removing  any van der Waals interactions 
holding  the protein core together. With these removed, heme insertion into the core is 
easier, as described by k3. Together these two parameters are the most pertinent to protein 
designs aiming to control the kinetics of the assembly reaction. 
The concept of a molten globular core has been discussed previously.21 Many 
protein design methodologies energetically minimize the structure they are generating  in 
the presence of a specific cofactor such that it has little to no motion at its lowest energetic 
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state. This makes the holoprotein very rigid with the hope that it tightly binds its cofactor. 
This can, however, have the problem of obstructing  binding  by shifting  the barrier to k3 as 
the core too rigid to allow heme to enter.  
The existence of a heme-partitioned state fills out the last place of the scheme. If a 
protein were able to bind cofactors without the need for ligating amino acids, different 
metals could be inserted into the tetrapyrrole skeleton and the redox properties would be 
significantly expanded. 
While being  a boon for protein design, this work also sheds light on the natural 
process of heme assembly. Many proteins are unstructured in their apo forms and the 
addition of heme induces a rigid holoprotein. It is possible this is an evolved trait aiming  to 
optimize heme-proteins assembly. This is not clear from any of the above data, as 
maquettes do not resemble natural proteins in any way, but the underlying physical 
chemistry applies to any four-α-helix bundle. Cytochrome b562 follows these principles, 
and it is likely that others would as well if examined more closely. 
We have developed, in this chapter, a complete understanding  of the mechanism 
and rate of the heme assembly in protein maquettes. This work builds on previous studies 
of Hargrove et. al. that stated specific residues are not important to the binding  rate.2 Here 
we agree with that work and expand on it; we demonstrate how the gross overall 
conformation and topology of the protein are critical, being the points at which the 
transition state is most affected. These concepts appear to match natural proteins such as 
b562, as this protein for example, like the single chain, undergoes a structural stabilization 
upon the apo to holo transition. More generally, this approach is applicable for natural and 
designed proteins. It can uncover the course of binding and remove barriers in the way.
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Chapter 4: The Cofactor Influence On Holoprotein Assembly Kinetics
4.1: Introduction  
 In this chapter the assembly of a holoprotein is examined with the effect of the 
cofactor being  the main focus. The previous chapter only addressed the cofactor itself to 
show that it is first order with respect to the reaction kinetics. Being  first order, it therefore 
plays an integral part in the assembly and its contributions need to be addressed. 
The only previous work that examined the kinetics of maquette-porphyrin binding 
was performed by Gibney et. al..1 Investigating the difference in the binding  of heme B and 
heme A in a designed 4-helix bundle, they observed heme A assembles at a slower rate. 
This was attributed to the farnesyl tail inhibiting requiring  burial in the core.  Other groups 
have examined the effect of adding  alternative hemes to globin proteins however, the 
underlying  physical chemistry was not addressed.2	  3 The effect of porphyrin aggregation on 
the assembly rate was previously addressed, however this was only with heme B, other 
cofactors with differing  structures were not considered.4  Using  Hemopexin they were able 
to describe the effect of aggregation on the assembly rate in a variety of environmental 
conditions. The work in this chapter aims to build upon that previous work, describing  how 
varying structures of tetrapyrrole cofactors affect the rate.
In this chapter, we fill in the final piece of Scheme 3.1. I aim to clarify how 
chemical aspects of the porphyrin control the assembly rate, and how it can be managed 
using a variety of natural and synthetic porphyrins structurally related to heme B. 
4.2: Results
4.2.1: Fe-Porphyrin Assembly And The Effect Of Substituents
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 In order to elucidate the effect the porphyrin has on holoprotein assembly we 
selected a series of porphyrins with different attributes to compare (Figure 4.1). The 
porphyrins selected all are standard tetrapyrroles with an iron center, however their ring 
substituents differ significantly as depicted in Figure 4.1. These different porphyrins were 
chosen based on their variety of substituents and, based on common chemical knowledge 
of water interactions, can be broadly divided up into three classes: (1)  Hydrophobic 
porphyrins (Etioporphyrin, Protoporphyrin IX Dimethyl Ester,) contain side-chains that do 
not have strong polar interactions with water; (2) Hydrophilic porphyrins 
(IsoHematoporphyrin, Tetracarboxyphenyl Porphyrin)  have side-chains that are polar or 
charged, therefore able to hydrogen bond to water; (3) Amphiphilic porphyrins 
(Protoporphyrin IX, Mesoporphyrin IX, Deuteroporphyrin IX, 2,6-Dicyanoporphyrin, 
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Figure	  4.1:	   The	  Library	   of	  porphyrins	  used	  in	  this	   chapter.	   These	  porphyrins	  
were	  chosen	  based	  on	  their	  diverse	  structures	  and	  substituent	  characteristics
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Diacetyl Deuteroporphyinr 
IX, and Heme a), which 
have both hydrophobic 
and hydrophil ic s ide-
chains. All of these are 
shown in Figure 4.1. 
 The various porphyrins 
were the rapidly mixed 
with the single chain 
proteins from the previous 
chapter and the binding 
rate was measured as the 
change in the Soret band 
of the porphyrin as a 
function of time (Soret 
bands A3.1-A3.12).  Figure 
4.2 shows this series of 
porphyrins binding  to the 
single-chain protein mentioned previously (rate constants listed in table 4.1). What 
emerges from the data is a general trend of the amphiphilic proteins with small substituents 
binding  with faster rates than the hydrophobic or hydrophilic porphyrins.  Hydrophobic 
porphyrins have the hardest time binding even with substituents as small as ethyl groups, as 
is the case with Etioporphyrin.
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Figure	   4.2:	   Assembly	   traces	   of	   the	   porphyrins	   from	  
eigure	   1	   (5µM)	   and	   the	   single	   chain	   protein	   (24µM).	  
Deuteroporphyrin	   (red),	   Mesoporphyrin	   (grey),	   Heme	  
(blue),	   Iso	   Hematoporphyrin	   (forest	   green),	   Diacetly	  
Deuteroporphyrin	   (black),	   Tetracarboxyphenyl	  
porphyrin	   (gold),	   2,6-­‐Dinitrile	   porphyrin	   (light	   green),	  
Etioporphyrin	  (pink),	   Protoporphyrin	  IX	  Dimethyl	   ester	  
(brown),	   and	   Heme	   A	   (Orange).	   All	   data	   collected	   in	  
20mM	  CHES	  150mM	  KCl	  buffer	  pH	  9	  at	  25˚C	  .	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 There appeared to be no direct relation between the rates and the assigned classes 
of hydrophobicity. I next quantified the solubility to better classify the porphyrins, and 
again investigate a relationship with the rates. This was measured in Partition coefficients 
(log-P values)  between octanol and 20mM CHES 150mM KCl buffer pH 9. The porphyrins 
were mixed in a 50/50 octanol/buffer mixture and allowed to incubate for one hour at 
room temperature. After this incubation the concentration in each phase were determined 
(Table 4.1). Figure 4.3 shows the rate constants plotted against the log  P values. In this 
figure there appears to be two trends. Mesoporphyrin is at the apex and from there if a 
porphyrin becomes either more or less hydrophobic the rate appears to drop. This can be 
explained by an amphiphilic-centered hypothesis. Having  to bury a polar group inside a 
hydrophobic protein core is energetically difficult causing  the rate to slow, and conversely 
having  to get insoluble porphyrins in solution is also difficult as those porphyrins have a 
propensity to aggregate. The ideal cofactor is one that has both hydrophobic character to 
aid in burial and hydrophilic character to increase its solubility. Figure 4.4 demonstrates 
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Porphyrin Rate constant Log-P Kd Values Em
   M-1 s-1 (CHES pH 9) (nM) (mV)
Hemin 82068 0.46254 <2 -261
Mesoporphyrin 484079 0.55195 <10 -319
Deuteroporphyrin 176639 0.65704 80 -268
IsoHematoporphyrin 58649 0.1196 1120 -236
DADPIX 30371 0.12379 <10 -48
Etioporphyrin 3796 1.4218 -- NA
FePPIX-DME 3140 0.85306 -- NA
Tetracarboxyphenyl porphyrin 12557 0.02769 -- -320
2,6-Dintrile porphyrin 7118 0.036413 -- *+150
Heme a 683 0.93846 -- ✝-145
Table	  4.1:	  Rate	  Constants,	  Partition	  Coefeicients,	  Kd	  values	  (where	  possible),	  and	  
Em	  values	  for	  the	  Fe-­‐porphyrins	  in	  this	  work.	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this with heme, the standard cofactor in this work. The heme vinyl groups contribute 
hydrophobic character and are easily buried in the protein core whereas the propionate 
groups contribute solubility, helping  the heme to remain in aqueous solvent and not 
aggregate. This 
hypothesis helps 
to explain why 
Mesoporphyr in 
binds with the 
highest rate. It has 
a m p h i p h i l i c 
character leading 
t o a l o w 
p r o p e n s i t y t o 
aggregate and 
ease of burial in 
the protein core. 
This correlation 
between rate and 
solubility can be 
used as a rough guide for porphyrin selection as this relationship appears to play some 
factor in the binding mechanism. 
In agreement with the kinetics, the thermodynamics indicate a need for a clear 
separation of hydrophilic and hydrophobic faces pH.  This work will be detailed in Kodali 
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Figure	  4.3:	  Log	  of	  rate	  constant	  (k)	  as	  a	  function	  of	  the	  partition	  
coefeicient	   (log-­‐P)	   in	   20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9.	  
Rates	  were	   taken	  from	   the	  previous	  graph.	   Log-­‐P	  values	  were	  
determined	   between	   CHES	   buffer	   and	   octanol	   at	   room	  
temperature,	   and	  allowed	  to	  equilibrate	  for	  approximately	  one	  
hour.	   	   	   With	   Mesoporphyrin	   appearing	   to	   bind	   the	   fastest,	  
becoming	  more	  hydrophobic	  or	  hydrophilic	  appears	  to	  slow	  the	  
assembly	  rate.
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et. al. (in preparation), showing  that tetrapyrroles with the highest affinities have a clear 
hydrophobic face and a clear hydrophilic face. 
 While the plots show a correlation between log-P values and binding rate it may 
not be as straightforward. 
I n a d d i t i o n t o v a s t 
differences in solubility, 
these porphyrins also have 
a vast difference in size. 
Etioporphyrin and heme A 
are both slow binding 
porphyrins. Though both 
have different log-P values 
they also have vastly 
different sizes of their ring 
substituents. Heme A has a 
large bulky farnesyl tail, 
and Etioporphyrin has, in 
that same C8 position, a 
far less bulky ethyl group. 
Despite both being  unable 
to interact with water, they have different interactions with the protein. The bulk of the 
farnesyl tail hinders the heme from getting  buried in the core, both because it is insoluble 
and because a large portion of the protein interior must conform to a bulky substituent. This 
is an obvious hindrance to this process, one not encountered with the smaller substituents 
59
     
Figure	   4.4:	   Illustrating	   the	   amphiphilic	   hypothesis	   in	  
heme.	   The	   pink	   shaded	   area	   denotes	   the	   hydrophobic	  
face	  while	  the	  blue	  shaded	  area	  denotes	   the	  hydrophilic	  
face.	   It	  is	  essential	  that	  a	  porphyrin	  has	  both	  to	  maximize	  
its	  solubility	  with	  interactions	  with	  the	  protein.
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on Etioporphyrin. The data here do not provide enough information to make clear whether 
solubility or size is the main barrier, 
 Fe-TCP is another example of size being  a possible hindrance to assembly. This 
cofactor has large carboxy-phenyl groups at its four meso-positions, and burying  these in 
the hydrophobic core incites two problems. First, there is a large amount of steric bulk, 
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Figure	   4.5:	   Afeinity	   titrations	   of	   a	   selection	   of	   porphyrins	   to	   the	   single-­‐chain	  
protein	  at	  10nM.	   The	  Iso	   Hematoporphyrin	   trace	  was	  done	  with	  2.9µM	  protein.	  
All	   titrations	   were	   done	   in	   20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9	   at	   room	  
temperature.	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requiring the protein to attain a new structure before binding, similar to heme A. The 
second is the burial of charged groups. Sequestering  these in a core devoid of water would 
require a large amount of energy. This energy would manifest in a kinetic barrier slowing 
assembly. 
 In an attempt to determine a relationship between the porphyrin affinity by protein 
and the rate the Kd values were measured for the soluble porphyrins. Figure 4.5 depicts the 
affinities for the four 
p o r p h y r i n s 
Deute roporphyr in , 
M e s o p o r p h y r i n , 
DA D P I X , a n d I s o 
Hematoporphyrin. The 
Kd values are listed in 
table 4.1. From the 
d a t a h e r e , n o 
discernible connection 
was made between the 
affinity and rate.
I next wanted to test 
any effect that resulted 
f rom a change in 
redox states. To test this effect, ferric and ferrous heme were rapidly mixed with the 
tethered homodimer protein and the Soret band was monitored over time (Figure 4.6). In 
this experiment assembled proteins were monitored by the shift in absorbance at the Soret 
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Figure	   4.6:	   Comparison	   of	   ferric	   (red)	   and	   ferrous	   (blue)	  
heme	  binding	  to	  the	  tethered	  homodimer	  protein.	  Protein	  at	  
10µM	   and	   porphyrin	   at	   5µM.	   Data	   collected	   at	   25˚C	   in	  
250mM	  Borate	  150mM	  KCl	  buffer	  pH	  9.	  	  Oxidized	  heme	  data	  
is	   the	   	   change	   in	  412nm	  over	   time,	   and	  Reduced	   heme	   is	  
change	  in	  427nm	  over	  time.
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band (Figure A3.1). The ferrous heme assembles with protein at a slower rate than the ferric 
state. This can be explained using the idea of solubility from above. The oxidized 
porphyrin’s Fe-center has a +1 charge due to the Ferric iron being in a +3 state and the 
porphyrin ring  having  a -2 charge. When this Fe is reduced to a plus +2 state the net charge 
of the tetrapyrrole ring  becomes neutral and the compound would have a higher propensity 
to aggregate in water causing  the rate to decrease. This is not the only explanation, it is also 
possible interactions with ligands are affected. The electronic environment of heme in the 
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Figure	   4.7:	   Comparison	   of	   ZnPPIX	   and	   heme	   assembling	   with	   the	   tethered	  
homodimer	  protein	  (A).	  Over	  the	  course	  of	  4	  seconds	  Zn	  appears	  to	  bind	  quickly	  
compared	   to	   the	   tethered	   homodimer.	   However	   the	   stoichiometry	   is	   not	  
consistent.	  This	  can	  be	  explained	  by	  looking	  at	  the	  stock	  of	  ZnPPIX	  (B).	  It	  is	  in	  an	  
aggregated	  state	  and	  precipitating	  out	  of	  solution.	  All	  data	  was	  collected	  at	  20˚C	  in	  
250mM	  Borate	  150mM	  KCl	  pH	  9.
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oxidized state may bind more tightly due to coulombic interactions having  a higher affinity 
for the lone pairs of histidine.  
4.2.2: Effect Of The Metal 
On Assembly 
Having looked at different 
Fe-centered porphyrins, I 
next investigated the 
effect of the metal center 
to determine if it has an 
effect on the rate. I mixed 
the tethered-homodimer 
protein with heme and 
Zn protoporphyrin IX 
(ZnPPIX) . These two 
porphyrins differ only by 
the metal at the center. In 
t h i s e x p e r i m e n t 
assembled proteins were monitored by the shift in absorbance at the Soret band (Figure 
4.8). Figure 4.7-A shows the traces of these two porphyrins over four seconds. Though the 
Zn appears to assemble faster than the Fe, the final stoichiometry is much lower. This is due 
to the aggregation of ZnPPIX that can be plainly seen in Figure 4.7-B. In this case, the 
solubility of ZnPPIX is a clear barrier to the assembly rate, significantly slowing it 
compared to iron. Based on this data, the metal appears to have a substantial effect, it 
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Figure	   4.8:	   ZnPPIX	   aggregate	   (prepared	   by	   leaving	  
ZnPPIX	   in	   buffer	   overnight)	   being	   broken	   up	   and	  
assembling	   with	   the	   single	   chain	   protein.	   Protein	   at	  
5µM	   and	   porphyrin	   at	   an	   unknown	   quantity	   due	   it	  
being	   in	  an	  aggregated	  state.	   Inset	   depicts	   the	  change	  
in	   the	   Soret	   band	   (427nm)	   as	   a	   function	   of	   time.	  
Experiment	  performed	  at	   room	  temperature	  in	  20mM	  
CHES	  150mM	  KCl	  buffer	  pH	  9.
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being  the only difference between these two porphyrins. Heme has been shown to 
aggregate in solution slightly however, not to the degree of ZnPPIX.4
4.2.3: Effect Of The Protein On Porphyrin Aggregates
Despite what is shown in figure 4.7 it is possible to achieve assembly and rescue a 
cofactor from an aggregated state, however the rate in this scenario is greatly slowed. 
Figure 4.8  shows a protein removing  ZnPPIX from an aggregate state. In this experiment, 
protein was added to a pre-aggregated sample of ZnPPIX and the absorbance at 427nm 
was monitored, the Soret band of protein-bound ZnPPIX. Over the course of 1.5 hours, 
binding  appears to be 
l i m i t e d b y t h e d e -
aggregation rate yet again. 
Th e p r o t e i n a p p e a r s 
capable of a deaggregase 
a c t i v i t y b r e a k i n g  u p 
aggregates of porphyrin 
and sequestering it.
4.2.4: Effect Of Porphyrin 
Skeleton On Assembly
The other aspect of 
the tetrapyrrole structure to 
be investigated for rate 
differences is the ring.  To 
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Figure	  4.9:	   Comparison	  of	  the	  assembly	  rates	  between	  
a	  similarly	  structured	  Zn	  centered	  chlorin	  (green)	  and	  
porphyrin	   (red).	   The	   saturation	   of	   a	   pyrrol	   ring	  
appears	   to	   increase	   the	   rate	   despite	   substituents	   and	  
metal	   being	   the	   same	   between	   the	   two.	   Data	   was	  
collected	  at	  20˚C	  in	  20mM	  CHES	  150mM	  KCl	  buffer	  pH	  
9.	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test this we used a pair of synthesized tetrapyrrole cofactors SE370, a chlorin type, and 
Zn-5-phenyl-15-carboxyphenyl Porphyrin (ZnPCPP), given to us by the Jonathan Lindsey 
and Sergei Vinogradov labs respectively. These two cofactors differ in structure by the 
saturation of a single pyrrole ring   and the addition of methyl groups (Figure 4.9). In this 
experiment assembled proteins were monitored by the shift in absorbance at the Soret 
band (Figure A3.19). The change in the ring  structure has an obvious effect; the rate 
increasing  when it is saturated. It is likely that any differences stem from the methyl groups 
or puckering  of the tetrapyrrole ring  breaking up aggregates or self-assembled oligomers in 
solution, providing monomeric chlorins for the protein to assemble with.
4.2.5: Test Of Solubility With A Synthetic Porphyrin
The Vinogradov group synthesized a new porphyrin taking  into account both the 
amphiphilic requirements that allowed me to test the amphiphilic theory directly with a 
Zn-centered porphyrin. This porphyrin is the ZnPCPP modified to have a newkome 
dendrimer (containing  3 carboxylic acid groups) for increased solubility. The binding  rate 
for this was compared to ZnPCPP from before. Figure 4.10 shows the comparison between 
these two rates. In this experiment assembled proteins were monitored by the shift in 
absorbance at the Soret band (Figure A3.19).  The newkome-porphyrin binds to the protein 
within milliseconds of being  exposed in a stopped flow, and majorly in the dead time of 
the instrument. As such no rate was fitted for this porphyrin.  This synthesized porphyrin 
has a zinc center, as it’s primary design goal was to end up as a light harvesting and 
electron transfer porphyrin.6 It is compared to a porphyrin that is structurally the same 
except that it does not have the newkome dendrimer. This porphyrin does not appear to 
bind at a comparable rate; its lack of a solubilizing  group hindering  this reaction. No rate 
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Figure	   4.10:	   Assembly	  kinetics	   of	  an	   insoluble	   porphyrin	   (red),	   and	   the	   same	  
one	   but	   with	   a	   chemical	   modieication	   aimed	   at	   solublizing	   it	   (green).	   The	  
soluble	   group,	   called	   a	   newkome	   dendrimer,	   greatly	   increases	   the	   rate	   of	  
assembly.	   All	   rates	   collected	  in	   20mM	  CHES	   150mM	  KCl	   buffer	   pH	   9	   at	   25˚C.	  
Protein	  at	  24µM	  and	  porphyrin	  at	  5µM.	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was fitted for this, as it appears to not bind. Though no rates could be determined, this 
clearly shows the effect of increasing  the solubility of a porphyrin on the assembly rate. 
Increasing from not binding at all to binding within the dead-time of the machine. 
4.3: Discussion
4.3.1: Porphyrin Control Over The Rate Of Assembly
 The data above describe the obstacles involved with selecting  a tetrapyrrole to 
assemble with a 4-helix bundle protein. More generally this data describes the kinetics of 
assembly from the perspective of the cofactor, any tetrapyrrole-binding protein could be 
affected by these factors.
Figure 4.3 highlights a major hindrance to cofactor binding.  Increasing the 
cofactor-binding  rate depends heavily on increasing  the cofactor’s amphiphilicity, 
measured here by partition coefficients. The best example of this is observed in the 
differences in assembly rate between heme B and Fe-PPIX-DME incorporation.  The only 
difference between these two cofactors is the methylation of the propionates, the overall 
structure is otherwise unperturbed, but simply removing the negative charges on the 
cofactor eliminates its solubility. The partition coefficient of heme B (0.46 Octanol/pH 9 
aqueous buffer) increases drastically (0.85 Octanol/pH 9) when in a PPIX-DME form, and 
the rate is similarly affected, decreasing from 8.2x104 M-1s-1 down to 3.1x103 M-1s-1. 
Heme can similarly be compared to the 2,6-Dinitrileporphyrin. These two cofactors 
have the same structure save for the vinyl groups at C3 and C8 being  converted to nitrile 
groups. The nitrile groups lower the log-P  value from 0.46 to 0.036 and the rate from 
8.2x104 M-1s-1 to 7.1x103 M-1s-1, an order of magnitude change in rate. In this case, the 
increased solubility hinders the rate by requiring  polar groups to be buried. The structure of 
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the porphyrin is not significantly changed but the assembly is greatly affected. Together 
these two examples point to the log-P value as being  highly correlated with the assembly 
rate. One can think of these as a guide to cofactor selection and a method of diagnosing 
potential barriers to binding.
Solubility, while appearing  to play a role in this process, is not necessarily the main 
factor.  Large cofactors, like heme A and Fe-TCP, are likely limited by substituent size as 
well.  Bulky sidechains would hinder assembly as the protein must adopt a conformation 
that can accommodate these large chemical groups. This is in contrast to the small groups 
on Mesoporphyrin or Deuteroporphyrin consisting  of ethyl and methyl groups respectively. 
These do not require significant conformational changes, the holoprotein can easily 
assemble. 
 Changes to the tetrapyrrole skeleton have noticeable effects on the assembly rate. 
Chlorins have a saturated pyrrole ring  as a signature part of their structure. This greatly 
changes their photo-physical and other inherent properties. In this context, it may speed up 
their assembly reaction with the protein by destabilizing  their aggregated state compared to 
a porphyrin with similar substituents.
4.3.2: Natural Relevance 
Nature has a variety of protein systems designed to control the assembly of holo-
proteins and circumvent issues with cofactor aggregation.  In many cases, tetrapyrroles are 
stored in proteins, such as HasA, which stores heme B.7 There are cytotoxic consequences 
brought on by free cofactor; it is known to aggregate,8 can generate an insoluble hemozoin 
crystal,9 and also has been shown to catalyze Fenton chemistry releasing reactive oxygen 
species (ROS).10 Aggregated heme also induces cellular pro-inflammatory-signaling 
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pathways. Aggregates of bacteriochlorophylls do not necessarily trigger Fenton chemistry 
because they lack iron, but their photophysical properties are changed substantially from 
the free cofactor, hindering  them from taking  part in light capture reactions.11  In either 
case, loss of a prosthetic group is a major issue to protein function and cell viability.
 Maquettes in  vitro do not have proteins to limit aggregates, and a change in 
solubility can impede assembly. However, maquettes do have an advantage over natural 
proteins in this regard. Their ability to bind both natural-modified cofactors and synthetic 
tetrapyrroles allows for changes in solubility to be made with little to no effect on the 
affinity or electrochemical properties.  
4.3.3: Conclusions
 The work in this chapter provides a rudimentary guide to tetrapyrrole cofactor 
selection when dealing with proteins. Though the work here uses exclusively 4-helix 
bundles proteins, the concepts are equally applicable as they pertain to the cofactor. The 
protein was chosen as it is the least likely to have a rate limiting step that would be slower 
than that of the de-aggregation or solubility issues here.  The rate-limiting step regarding 
the cofactor in assembly does not change.
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Chapter 5: Midpoint Potential Control In A Series Of Maquettes 
5.1: Introduction
 In natural systems many oxidoreductase functions are carried out with a heme B 
cofactor. These range from electron transfer to oxygen binding  and alkane hydroxylation.1-3 
One major aspect of the heme that allows it to have such diverse roles is its midpoint 
potential (Em).4 This thermodynamic parameter is a measure of how reducing  the heme is, 
and its control is crucial to the protein properly achieving its intended function.
 For many years maquettes have been used to study how the protein exerts control 
over this parameter. Brian Gibney and Julia Shifman studied a previous generation of 
maquettes related to the unstructured homotetramer protein of chapter 3. In the H10A24 
protein they were able to increase the heme B midpoint potential from approximately 
-200mV up to -100mV using  environmental factors, and charge effects.5-8 This 2.3 kcal/mol 
change is impressive but still far from the range seen in natural systems, which can reach 
upward of +400mV or 9.22 kcal/mol.5
In this chapter, I study how holoproteins modulate the midpoint potential in a new 
generation of designed proteins, more malleable and asymmetric than the ones used 
previously, a consequence of them being  monomeric.9 This asymmetry allows for the 
creation of separate environments within the same protein and more control over ligation 
states. Through well known potentiometric methods,4 I was able to show how various 
changes to the protein and heme affect the Em, shedding  light on this process in natural 
systems.  
From a design perspective, this chapter demonstrates the most basic principles 
underlying  construction of a synthetic oxidoreductase protein. From selection of cofactor to 
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placement and midpoint potential, the principles in this paper can be used to tailor 
maquettes to be able to perform any redox function.
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Figure	  5.1:	  Helical	  wheels	  of	  the	  single	  chain	  protein	  (A),	   and	  a	  positive	  variant	  of	  
that	  design	  (B).	  Heme	  binding	  His	   residues	  are	   colored	  green,	   positively	  charged	  
residues	   are	   colored	   blue,	   negatively	   charged	   residues	   are	   red,	   polar-­‐uncharged	  
residues	  are	  in	  yellow,	   and	  hydrophobic	  residues	  are	   in	  purple.	  These	  helices	   can	  
be	  connected	  in	  various	  ways	  as	  shown	  below:	  All	  negative	  (C),	  mixed	  half	  positive	  
and	  half	   negative	   (D),	   and	   all	   positive	   (E).	   The	   various	   combinations	   of	   helices	  
afford	  the	  protein	  different	  sets	  of	  attributes	  that	  relate	  to	   the	  charge	  imposed,	  the	  
hydrogen	  bonds	  formed	  	  and	  the	  burial	  of	  certain	  amino	  acids.	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5.2: Results
5.2.1: Environmental Changes 
The first set of changes aimed at 
effecting  the midpoint potential is 
a l t e r ing  the gene ra l cha rge 
patterning of surface residues. 
Figure 5.1 (Panels A and B) shows a 
comparison of two individual 
helices that have different  net 
charges along  the outside of the 
helix. These have been combined to 
form three 4-α-helix bundles with 
different charge properties (Figure 
5.1 C-E). Starting with the single 
chain prote in f rom previous 
chapters (FIgure 5.1-C), whose net 
charge is -16; the charge pattern 
along  the outside was altered such 
that the net charges become -2 
(Figure 5.1-D) and +11 (Figure 5.1-
E).  
 To test for the any change in 
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Figure	   5.2:	   Melts	   of	   apo-­‐state	   of	   the	   single-­‐
chain	   (red),	   the	   binary	   single	   chain	   (green),	  
and	  the	   positive	  mutant	   (blue).	   Using	   helices	  
from	   eigure	   5.1,	   three	   distinct	   designs	   were	  
generated,	   all	   with	   varying	   Tm	   values,	   Single	  
chain:	   37˚C,	   Binary:	   48˚C,	   and	   Positive:	   55˚C.	  
These	   different	   Tm	   values	   are	   brought	   on	   by	  
differences	   in	   charge	   patterning	   along	   the	  
surface	   of	   the	   protein	   generating	   coulombic	  
pairing	   between	   amino	   acids.	   Data	   for	   the	  
single	   chain	   and	   binary	   were	   collected	   by	  
Goutham	   Kodali.	   All	   three	   melts	   were	  
performed	   in	  20mM	  CHES	   150mM	   buffer	  pH	  
9 .	   A l l	   p ro te in	   concentra t ions	   were	  
approximately	  5µM
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stability, circular dichroism (CD) temperature melts were performed (Figure 5.2). The 
positive mutant, thanks to an increase in charge pairing along  the helical surface is 
rendered more thermostable by 0.6 kcal/mol (a Tm increase from 37˚C to 55˚C). The binary 
mutant has a Tm of 48˚C, which is between the positive and negative charged variants, as 
expected. It is unclear from these data whether or not there are multiple transitions 
overlaid. NMR could not be done on the positive mutant due to aggregation issues above 
30µM. 
The Kd value was also examined to ensure heme affinity would not complicate 
measurements. Figure 5.3 depicts the binding titration of the positive mutant compared to 
the single chain variant from before. There is a noticeable increase in this parameter, going 
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Figure	  5.3:	  Comparison	  of	  the	  single	  chain	  protein	  (A)	  and	  the	  positive	  variant	  
(B)binding	  afeinities.	   Protein	  was	  at	  6nM	  in	  (A)	  and	  5µM	  in	  (B).	   The	  addition	  of	  
positive	  charges	   causes	  a	  severe	   lowering	  of	  the	  afeinity,	   driving	  it	  up	  from	  sub-­‐
nanomolar	   to	   micromolar.	   Titrations	   were	   done	   in	   20mM	   CHES	   150mM	   KCl	  
buffer	   pH	   9	   at	   room	   temperature.	   The	   concentration	   of	   heme	   (in	   Molar)	   is	  
depicted	  on	   the	  x-­‐axis.	   Note	  the	   difference	   in	  order	   of	  magnitude	  between	   the	  
two	  proteins
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from sub-nanomolar up to 1.5µM. Though this sequence change resulted in a loss of 
affinity it was not severe 
enough to p roh ib i t 
further studies.
T h i s c h a r g e 
p a t t e r n i n g  h a s a 
significant effect altering 
the midpoint potential. 
In the s ingle chain 
variant the Em value is 
-290mV, which starts 
with a charge of -16. In 
the binary mutant this Em 
is split, accounting  for 
t h e m u l t i p l e 
e n v i r o n m e n t s , t o 
-224mV and -151mV. In 
the positive variant, the 
sp l i t i s once aga in 
removed and the higher 
potential remains, -151mV (Figure 5.4). The positive charged and negative charged proteins 
were fit to a single 1-Em curve, while the binary mutant was fit to a 2-Em curve (see 
materials and methods). This is a 3.22kcal/mol difference between the -16 and +11 charge 
patterns of the single chain, and postive variant maquette (140mV Em difference). This large 
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Figure	   5.4:	   Altering	   the	   charges	   along	   the	   outside	  of	   the	  
protein	  can	  allow	   for	  a	  signieicant	  change	  in	  the	  midpoint	  
potential	   of	   a	   heme	   B	   cofactor.	   Blue	   Diamonds:	   -­‐16	  
charged	   single	   chain	   protein	   with	   one	   heme,	   midpoint	  
potential	   of	   -­‐260mV.	   Black	   Squares:	   +11	   charged	   single	  
chain	   protein	  with	   two	   heme	   cofactors,	   both	   potentials:	  
-­‐151mV.	   Green	   Circles:	   Binary	   charged	   single	   chain	  
maquette	   with	   two	   heme	   cofactors.	   This	   shows	   two	  
potentials	   at	   -­‐151mV	   and	   -­‐225mV,	   a	   substantial	   shift.	  
Titrations	  were	   done	   at	   room	   temperature	   in	  Phosphate	  
buffer	  pH	  8.	   All	   proteins	   at	  25µM.	  Mediators	  are	   listed	   in	  
the	  Materials	   and	  Methods	  section.	   Titrations	   carried	  out	  
at	  22˚C	  in	  100mM	  PO4	  150mM	  KCl	  pH	  9
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split between the two comes to approximately 5mV/charge, a value that does not match 
11-14mV/charge seen in the literature.10 However, the binary mutant has two different 
midpoint potential values, and based on the sequence similarity, it is reasonable to assume 
that the two positive helices in the binary mutant contain the heme with a -151mV Em 
value. In this case, half of one protein is modified, the change in charge is only 12, which 
gives an 11.6 mV/charge change (0.26 kcal/mol-charge), well in line with previous studies. 
There also appears to be a 
crossover effect from the 
positive helices raising  the Em 
of the heme bound to the 
negative helices from -290mV 
up to -224mV (∆Em = 66mV, 
1.5 kcal/mol). This is most 
likely due to buried lysine 
residues in the core mildly 
destabil izing the nearby 
positive ferric heme B.  
 T h i s e x p e r i m e n t 
clearly shows the maquettes 
a b i l i t y t o c r e a t e E m 
d i f f e r en t i a t i on be tween 
separate heme sites. This site 
independence can be seen with another example of charge patterning. The homo-dimeric 
protein F56HA3 has two domains, one of which has glutamates buried near the heme and 
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Figure	   5.5:	   Redox	   Titration	   of	  the	   F56HA3	  protein.	  
The	   independence	   of	  helices	   allows	   for	   a	  modular	  
control	   over	   the	   midpoint	   potential	   as	   well	   as	  
functions.	   One	   helix-­‐pair	   has	   had	   glutamates	  
replaced	  with	  alanines	   causing	   a	   100mV	  midpoint	  
potential	  split	  (-­‐290mV	  and	  -­‐190mV),	  see	  sequence	  
appendix.	  Mediators	  are	   listed	  in	  the	  Materials	  and	  
Methods	   section.	   Titrations	   carried	   out	   at	   22˚C	   in	  
20mM	  CHES	  150mM	  KCl	  pH	  9.	  Holoprotein	  at	  25µM.
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the other has alanines in place of them (Sequence Appendix). The effect of this differences 
is observed through a midpoint potential shift from -290mV to -190mV, a difference in the 
two Em values is 100mV 
(Figure 5.5), and is similar 
t o t h a t s e e n i n t h e 
H10A24 protein.5 This 
difference in potential 
a r i s e s f r o m p l a c i n g 
negatively charged Glu 
residues near the heme in 
o n e d o m a i n . T h i s 
stabilizes the ferric heme 
by 2.3kcal/mol through 
columbic interactions. 
Wi th these re s idues 
removed the charge 
s tab i l i za t ion i s a l so 
removed, leading  to an 
increase in the midpoint potential.  Here, the curve was fit to a 2-Em Nernst curve fit (see 
materials and methods).
Changing  the midpoint via charge patterning  is not a trivial matter of placing 
charges near the heme. Farid et al have shown that making  a single tryptophan to lysine 
mutation near the heme is not sufficient to shift the potential significantly.9 This change 
resulted in an approximately 10mV increase. Though in agreement with literature values, 
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Figure	  5.6:	  Redox	  titrations	  of	  the	  mutants	  E8A	  (red)	  and	  
E57A	  (blue).	  Each	  mutant	  shows	  similar	  Em	  values	  of	  
-­‐283	  and	  -­‐307	  respectively.	  Further	  proof	  that	  shifting	  the	  
midpoint	  of	  heme	  in	  maquettes	  requires	  more	  signieicant	  
mutations.	   Mediators	   are	   listed	   in	   the	   Materials	   and	  
Methods	   section.	   Titrations	  carried	  out	   at	  22˚C	  in	  20mM	  
CHES	  150mM	  KCl	  pH	  9
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this change is not outside of the error of the potentiometric method used. More significant 
charge modifications are needed to make an impact on the potential. 
Further proof that solitary charge modifications are not sufficient to increase the 
potential was needed to confirm the observation of Farid et. al.. The proteins E8A and E57A 
were chosen (Sequence Appendix). Potentiometric analysis does not show a substantial Em 
shift compared to the original tethered homodimer, all Em values are approximately 
-280mV (Figure 5.6). The mutation of two glutamate residues is not enough to cause a shift 
comparable to that seen in the F56HA3 mutant. Here, the curve was fit to a 1-Em Nernst 
curve fit (see materials and methods).
5.2.2: Ligation Changes
 Different porphyrin ligations are common in natural proteins, and often shift the 
potential significantly.11 Figure 5.7 demonstrates the change in Em when a bis-his ligation is 
mutated to his-cys. This change causes the Em to change from -260mV to -280mV. Though 
slight, this change also opens up the possibilities for other functions as the cys residue is 
used as a ligand in many P450 enzymes.1,12 Going one step further and changing  the 
ligation to cys-ala has a more profound effect on the midpoint potential, raising  it from 
-260 to approximately -165mV, (95mV difference). This ligation change also yields spectra 
that correspond to a 5-coordinate state typically seen in P450s (Figure 5.8). Here, the three 
curves were fit to a 2-Em Nernst curve fit (see materials and methods).
 Ligation changes are not as robust as environmental changes. While cysteine 
residues are tolerated, both with a distal his residue or without, other ligations tend to not 
have a comparable affinity. Methionine-histidine ligation pairs, like those seen in the 
natural protein b562, do not bind heme in maquettes.13 This lack of affinity is also seen in 
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n a t u r a l s y s t e m s . 
C h a n g i n g  t h e M e t 
residue of b562 to a 
Histidine increases the 
affinity by at least 100 
fold.11 
 S i n g l e h i s 
binding  sites also do not 
h ave t h e r e q u i s i t e 
affinity for these studies. 
In maquettes, a single 
heme site is unable to 
b i n d h e m e w i t h a 
measureable Kd value. 
Efforts to improve the 
binding  site have also 
met with failure. Single 
cys residue sites have been successful as these are thought to be aided by the thiolate 
group generating  an ionic bond between the negatively charged sulfur and the positively 
charged heme-Fe to improve the affinity.  
5.2.3: Using Cofactors To Shift The Potential
 In order to explore other methods to change the midpoint potential of heme inside 
a protein I moved another heme-cofactor to within van der Waals distance so that the two 
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Figure	   5.7:	   Redox	   titration	   of	   bis-­‐his	   (black),	   his-­‐cys	  
(blue),	   and	   cys-­‐ala	   (green)	   ligations	   in	   the	   single	   chain	  
protein.	   All	   done	   in	   Phosphate	   buffer	   pH	   8	   at	   room	  
temperature	   with	   25µM	   protein.	   The	   his-­‐cys	   ligation	  
scheme	   does	   not	   have	   a	   substantial	   effect	   on	   the	  
midpoint	  potential,	   lowering	  it	  from	  -­‐260mV	  to	  -­‐280mV.	  
The	  cys-­‐ala	  ligation	  however,	  has	  a	  large	  effect	  raising	  the	  
Em	   to	   -­‐165,	   a	  95mV	  increase.	   Mediators	   are	  listed	  in	  the	  
Materials	  and	  Methods	   section.	   Titrations	   carried	  out	  at	  
22˚C	  in	  100mM	  PO4	  150mM	  KCl	  pH	  9
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h e m e - c o f a c t o r s wo u l d b e 
electronically coupled.  This 
involved moving  the ligating 
histidine amino acids up one 
h e p t a d i n t h e t e t h e r e d 
homodimer protein. The first 
attempt to achieve two hemes in 
contact was to move the second 
heme adjacent with the first 
(Figure 5.9-Adjacent). This was 
successful when done in the 
H10H24 maquette, as seen in the 
work of Robertson et. al..7,14 The 
adjacent-tethered homodimer 
was not able to bind heme 
sufficiently as the decrease in conformational freedom does not provide enough room. To 
address this, the next variant moved the heme down one heptad such that the two 
cofactors were now “Offset” to one another (Figure 5.9-Offset). This comes at a cost of a 
higher Kd value, in the micromolar range (Figure 5.10). The weakened Kd is thought to be 
from crowding and steric clashes of 2 heme cofactors buried in the core. In previous 
variants such as H10A24 this is not a problem. The reason for this has to do with the way 
the heme binds and the protein’s oligomeric state. H10A24 is a homodimer and the heme 
binds not between two separate dimers, but two helices of one dimer (Table 3.1). This 
alleviates crowding by allowing the two separate pieces to mildly dissociate from one 
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Figure	   5.8:	   The	   Cys-­‐Ala	   maquette	   boucnd	   to	  
ferric	  heme	  shows	  UV/Vis	   spectra	  equivalent	   to	  
ferric	  cytochrome	  P450	  in	  the	  5-­‐coordinate	  state.	  
Figure	  provided	  by	  Goutham	  Kodali.	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another generating  more room to accommodate two cofactors. In the candelabra, as it is 
linked at the bottom, that is not an option. The lack of conformational freedom brought on 
by the disulfide bond restricts the binding sites. The offset protein also falls victim to 
crowding  but not enough to eliminate binding. Attempts to recreate this in the single chain 
protein were fruitless. Due to the extra loop, this protein has even less conformational 
freedom at either end than the tethered homodimer and heme could not bind 2 heme 
cofactors in offset positions. Attempts were made to make more room in the binding  site by 
removing  bulky amino acids in the core, however, heme binding  did not improve. Steric 
clashes brought on by the lack of conformational freedom appear to dominate when it 
comes to alternate heme placement. 
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Figure	   5.9:	   Pymol	   models	   of	   the	   three	   possible	   placements	   of	   heme	   in	   the	  
tethered	  homodimer	  maquette.	  The	  original	  model	  had	  both	  heme	  cofactors	  at	  
opposite	   ends	   of	   the	   protein	   (distant).	   Offset	   and	   Adjacent	   were	   attempted	  
however,	  only	  the	  offset	  variant	  was	  able	  to	  accommodate	  two	  heme	  cofactors	  in	  
one	  protein.	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Despite these various affinity issues, Figure 5.10 shows redox titration of the offset-
candelabra mutant with Em values of -280mV and -180mV, a split of 100mV. This effect 
stems from the positive charge on one heme affecting  the other one nearby changing  the 
∆G of reduction by 2.3  kcal/mol. The affinity for the reduced heme is not as high as for the 
oxidized, and when the heme is reduced it dissociates from the protein, as such, only the 
first reductive direction is depicted. Here, the  offset data was fit to a 2-Em Nernst curve fit 
while the homodimer data was fit with a 1-Em Nernst curve (see materials and methods).
5.2.4: Using Alternative Porphyrins
 The other method investigated to change the midpoint potential of the heme was to 
simply change the heme itself to a different Fe-centered porphyrin. Here we used the array 
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Figure	   5.10:	   Redox	   titration	  (A)	  of	   the	   offset	   mutant	  with	   two	   heme	   cofactors	  
bound.	   The	   proximity	   of	   the	   two	   cofactors	   causes	   a	   split	   in	   potentials	   of	  
approximately100mV	   (-­‐290,	   and	   -­‐180).	   Titration	   was	   performed	   at	   room	  
temperature	   in	   250mM	   Borate	   150mM	   KCl	   buffer	   pH	   9	   with	   25µM	   protein.	  
Mediators	  are	  listed	  in	  the	  Materials	  and	  Methods	  section.	  (B),	  Kd	  titration	  of	  the	  
Offset	  mutant.	  The	  proximity	  of	  the	  two	  heme	  cofactors,	   though	  possible,	  lowers	  
the	  afeinity	   to	   micromolar	   level.	   Titration	   done	   in	  Borate	  buffer	   pH	   9	  at	   room	  
temperature.	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of synthetic porphyrins from the previous chapter and obtained Em values for the ones that 
bind sufficiently (Etioporphyrin and protoporphyrin IX dimethyl ester were not included 
due to difficulties in binding).  Figure 5.11 show a large range of potentials spanning over 
350mV, all with the single chain protein and similar Kd values (Table 4.1).  Here, all of the 
porphyrin data were fit to 1-Em Nernst curves (see materials and methods).
 As shown above, one heme has a potential of -260mV in the single chain protein. 
Using  the porphyrins I can expand the range of potentials in maquettes not only in the 
more oxidizing direction but also the more reducing direction (Table 4.1 Figure 5.11). 
Mesoporphyrin despite differing  by a minor structural change has a 60mV shift downward. 
This saturation of the vinyl groups of heme appears to alter the electron density on the 
tetrapyrrole ring, stabilizing the Ferric (III)  state. This is not the case with Deuteroporphyrin 
whose midpoint is -270. The structural difference is minor however the potential difference 
is more significant. It is possible that the conversion of the two ethyl groups to methyl, 
removing  two CH3 groups, allows more water near the heme changing  the interactions 
with the protein core increasing  the potential by solvating  the porphyrin. Fe-
Tetracarboxyphenyl porphyrin (TCP) has electron donating  groups in the form of four 
carboxyphenyl substituents that drive the potential down 40mV. 
 The rest of this series of porphyrins change the potential in the positive direction 
(Table 4.1, Figure 5.11). IsoHematoporphyrin has a potential of -236mV. This is most likely 
caused by not the hydroxyl groups withdrawing  electron density but rather them increasing 
the water concentration in the core. Hydroxyl groups are polar as they have hydrogen 
bond acceptors from the oxygen lone pairs and donors from the hydrogen. These could 
helps stabilize water inside the core of the protein by bonding  with them and allowing 
them to interact with the tetrapyrrole. Heme A has an Em of -145mV most directly from an 
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electronegative formyl group directly attached to the porphyrin ring. The addition of 
another electron withdrawing  group, as seen in DADPIX, causes the porphyrin to have a 
potential of -48mV. This porphyrin has the two vinyl groups of heme B replaced with highly 
electronegative acetyl groups. Compared to one formyl group in heme A, the two here 
have a similar effect, raising the potential approximately 100mV/carbonyl group.  
 Past work from the lab performed by Sarah Chobot and Bruce Lichtenstein has 
added another porphyrin to the list.15 The 2,6-Dinitrileporphyrin Em value was obtained in 
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Figure	  5.11:	  Reduction	  potentials	  of	  the	  Fe-­‐porphyrins	  able	  to	  bind	  to	  the	  single	  
chain	  protein.	  All	  titrations	  done	  at	  25µM	  except	  heme	  A,	  which	  was	  done	  at	  an	  
unknown	  concentration	  due	  to	  poor	  afeinity.	  All	  titrations	  done	  in	  20mM	  CHES	  
150mM	   KCl	   buffer	   pH	   9	   at	   room	   temperature.	   Mediators	   are	   listed	   in	   the	  
Materials	  and	  Methods	  section.	  Data	  summarized	  in	  Table	  4.1.
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the candelabra protein as opposed to the single chain, which is not thought to be a factor 
considering  the similarity of sequence and Em values of heme B in either protein. The 
replacement of the two vinyl groups with nitrile ones places two incredibly electron 
withdrawing groups directly attached to the heme causing  the most massive shift seen in 
this work, up to +150mV (Table 4.1, Figure 5.11).    
 As expected the porphyrins with the more electron withdrawing  groups, such as 
Diacetyl Deuteroporphyrin IX with its two acetyl groups directly connected to the 
porphyrin ring, have higher potentials compared to those with electron donating  or 
electron neutral groups such as Iso Hematoporphyrin which has hydroxyl groups two 
methylene groups away from the porphyrin ring, only marginally interacting  with the 
electronics. 
5.3: Discussion
5.3.1: Midpoint Potential Changes Compared To Previous Maquette Work
 In this chapter I attempted to alter the midpoint potential in a new series of 
maquette proteins. Only through changing the porphyrin was I able to get out of the range 
achieved by Gibney and Shifman in their earlier work. One common drawback that all 
maquettes have compared to natural proteins is the burial of the heme away from water. 
Natural proteins often bury the heme cofactor away from solvent. This takes cofactors from 
the high dielectric of water to the much lower dielectric of the protein core where charges 
are not stable. In maquettes the heme is not so buried, and it is unknown how dry the core 
is. As such, the dielectric inside the protein may be higher and the positive ferric-heme 
cofactor more stable. 
 Changing  the potential of heme to match nature is still out of reach in maquettes. 
Nature has evolved hemoproteins incorporating  many of the chemical concepts seen 
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above to shift the potential an impressive range along with burial of the cofactor away from 
water (Figure 5.12). Having  established the magnitude of each modification, extending the 
Em range appears to be a matter of combining  them together. As seen in Figure 1.2, many 
proteins in the respiratory chain remove the heme from water, sequestering it in the 
membrane, and combine that with alternative ligations, other cofactor placement or 
environmental effects to shift the potential by ~400mV.
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Figure	   5.12:	   Summary	   of	   the	   ranges	   of	   midpoint	   potential	   values	   seen	   in	  
maquettes,	  and	  in	  natural	  proteins.	  Maquette	  values	  are	  from	  this	  work,	  and	  the	  
natural	  proteins	  are	  adapted	  from	  Shifman	  et.	  al..5
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 Despite me being  unable to achieve midpoint potentials out of the range of Gibney, 
Shifman et. al., I was able to show a  shift the potential in novel ways. Due to the symmetry 
imposed by the earlier maquettes separate environments were impossible. In this current 
generation, splitting  the potential of two heme cofactors by 100mV in the same protein 
13Å away from one another. In addition to that, switching  the ligands from bis-histidine to 
Cys-Ala and His-Met was not possible before either. These not only can shift the Em value 
but can lead to more diversity in function. 
5.3.2: Magnitude Of The Potential Changes In A New Generation Of Maquettes
 Changes in Em of 361mV were seen upon changing the porphyrin, going  from 
-311mV with Mesoporphyrin up to 50mV with the 2,6-Dinitrileporphyrin in the same 
protein (Table 4.1). Adding  electron-withdrawing  groups to the porphyrin greatly adjusts 
the redox potential, an effect seen in nature between groups like heme B and heme A.16
 A major advantage with this system is the affinities of maquettes for the various 
porphyrins. DADPIX and Mesoporphyrin, with potentials at -48mV and -319mV 
respectively, both have sub-nanomolar affinities with the single chain porphyrin (Table 4.1).
 Changing  the protein sequence to alter the charge environment is another way to 
shift the potential. However, this appears to have an upper limit of 150mV, as further 
charge modifications cause the protein to aggregate. Despite that limitation, a major 
advantage is the ability to include two separate charge domains in a single protein.9 
5.3.3: Conclusions
 Protein modularity is an important aspect of the maquette platform.  Being  able to 
generate two separate environments, with two separate Em values, allows one to control the 
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direction and speed of electron transfer in a protein system. Having cofactors at various 
distances is the first step to reproducing  electron transport chains similar to the ones seen 
in nature, creating a pathway of cofactors with increasing Em values for electrons to follow.   
 The range of potentials, and different ways of achieving  them, make maquettes the 
best way to study of protein electron-transport chains as well as the invention of novel 
oxidoreductase functions in a protein scaffold. Maquettes are capable of reproducing 
natural electron transfer reactions both the driving force (Em), as well as the distances 
between cofactors. From these parameters, according the established Moser-Dutton 
guidelines of electron transfer,20,21,22 the rates can be easily controlled in this system, to the 
point where maquettes can artificially replicate the events of nature.  
 The work in this chapter will be invaluable when maquettes are to be transitioned 
into living  cells. Not only will they have to assemble with cofactors, but they will have to 
regulate the electrochemistry of the cofactors as well. Using what has been shown here, 
this transition will be straightforward, and maquettes will be able to both incorporate into 
natural electron transfer processes as well as form their own.
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Chapter 6: Functions Possible In Maquettes When The Assembly Is 
Understood
6.1: Introduction
 The main focus of protein design is to learn about protein function through 
designing  a series of natural and engineered activities. How specifically to do this differs by 
approach, but all approaches aim to generate enzymatic reactions, and learn how proteins 
have evolved to be the catalysts they are. 
 As discussed in previous chapters, assembly and environment are key issues 
underlying  any function. The past chapters of this thesis have investigated these aspects in 
protein maquettes describing how the protein itself contributes to making a functional 
holo-protein. In this section we describe a series of functions carried out by these proteins 
using  tetrapyrrole cofactors, the designs of which were aided by our newfound knowledge 
of protein biophysical chemistry. 
6.2: Results
6.2.1: Electron Transfer
 The first function I attempted to recreate is a simple demonstration of electron 
transfer between two maquettes, reproducing  the many electron transfer reactions common 
to oxidoreductase proteins.1 I assembled two separate proteins using  what I have learned 
about modulating midpoint potential.  The first protein is heme B bound to the single-chain 
protein. This had a measured midpoint potential of -260mV. This was mixed with another 
single-chain protein containing Diacetyl Deuteroporphyrin IX (DADPIX) that has an Em 
value of -50mV. Together, these two proteins generate a 210mV driving force between the 
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pair, or a ∆G of -4.84 kcal/mol (Figure 5.11, Table 4.1). Figure 6.1A shows a spectral trace 
at 454nm, the reduced DADPIX soret peak, as a function of time. This peak appears while 
the reduced heme peak at 427nm decays (trace not shown). Figure 6.1-B shows UV/Vis 
spectra at three separate time points throughout this experiment. The arrows are 
highlighting  the growth of the reduced DADPIX. These experiments were done at 15°C in 
CHES buffer pH 9, and the absorbance at 314nm, the absorbance maximum of dithionite, 
was monitored to assure no excess reductant was present.
 These two proteins exchange electrons at a rate of approximately 5.8x10-7 M s-1, a 
rate 3.6 times faster the calculated diffusion limited rate of 1.62 x10-7 M s-1. The calculated 
diffusion-limited rate constant was determined through the following equation2
kd = 4πR (DHeme + DDADPIX)
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Figure	   6.1:	   Demonstration	   of	   electron	   transfer	   between	   two	   maquettes	   using	  
different	  cofactors.	  Here	  showing	  5μM	  heme	  in	  the	  single	  chain	  negative	  protein	  
transferring	  an	  electron	   to	   5μM	  DADPIX	   in	  the	   single	   chain	   protein.	   Panel	   (A)	  
depicts	  the	  increase	  of	  absorbance	  at	  454nm,	  the	  Soret	  band	  of	  reduced	  DADPIX.	  
The	   spectra	   of	   which	   are	   shown	   in	   (B)	   Spectra	   collected	   in	   a	   stopped-­‐elow	  
apparatus	  at	  20˚C	  in	  CHES	  buffer	  pH	  9.	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Where kd is the diffuison limited rate constant, R is the critical distance at which a 
reaction will take place, and D is the diffusion coefficient which can be determined 
from the following equation:2
 
kb T
 a
D =
Where kb is boltzmann’s constant, T is the temperature in Kelvin, η is the viscosity of the 
solution (here assumed to be 1.002 MPa•sec, the value of water at 20˚C), and a is the 
radius of the molecule at which a reaction will take place (here assumed to be 10Å).2
 The two diffusion constants (D) were both assumed to be the same as the difference 
between the two samples is a partially buried porphyrin, and the protein used was the 
same in both samples. This value was calculated to be 4.289x10-10 m2 s-1, which gives a kd 
of 1.078x10-17m3 s-1. Multiplying by Avagadro’s number and accounting  for m3 into liters 
converts this value into a rate constant of 6.493x103 M-1 s-1. Multiplying  this value by the 
concentration of each protein species (5µM each) gives the final rate of 1.62 x10-7 M  s-1. 
The experimental rate was obtained from the slope of a linear regression fit to the first 1.5 
seconds of the reaction (Figure 6.1A Inset). 
 Despite the slight discrepancy, these two rates are very close to one another, 
indicating  that the reaction is likely diffusion limited. The calculated rate however made 
some assumptions that could account for the discrepancy. First, the calculation assumed 
that the viscosity of the solution at 20ºC was that of water (1.002 mPa sec), not water with 
salt and pH 9 buffer, which would increase the viscosity. Furthermore, the viscosity was not 
altered, a common test of diffusion limited reactions. The other assumption, that 13Å was 
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the distance at which the two proteins had to be from one another before they would 
transfer electrons (assuming  a reorganization energy of 0.7). It may be farther considering 
the high driving  force for this 
reaction (-4.84 kcal/mol). 
 As a control to provide 
fur ther suppor t tha t th i s 
reaction is occurring, and it is 
not an art i fact of excess 
reductant, the reaction was also 
done with a CO trapped heme 
r e d u c e d s t a t e ,  o r a 
carboxyferrous state. Doing  this 
allowed for a scrubbing  of 
dithionite by bubbling  through 
oxygen gas, which can be 
replaced with an inert gas when 
the experiment begins (Ar was 
used in this experiment). Upon a light flash from a projection lamp, CO is photolysed from 
the heme and the electrons are free to be transferred. This is seen in figure 6.2, where upon 
the addition of light, the heme appears to go oxidized while the DADPIX appears to not 
only go reduced, but also bind CO. This method is limited in the sense that kinetics could 
not be obtained. 
Inter-protein electron transfer has been done many times before with natural 
proteins, but has not yet been examined with two synthetic proteins. This data shows not 
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Figure	  6.2:	  Electron	   transfer	  at	   low	   temperatures	  
between	   heme	   and	   DADPIX	   in	   the	   single	   chain	  
protein.	   The	   system	   was	   setup	   with	   reduced	  
holoprotein	   bound	   to	   CO	   mixed	   with	   oxidized	  
DADPIX-­‐holoprotein	  (black	   trace).	   The	   setup	  was	  
elashed	  to	  remove	  the	  CO	  from	  the	  heme	  and	  allow	  
electron	  transfer	  (blue	  trace),	  and	  then	  allowed	  to	  
fully	   oxidize	   (green	   trace).	   Each	   holoprotein	   at	  
5µM	  and	  data	  collected	  at	  -­‐10˚C	  in	  CHES	  buffer	  pH	  
9	  with	  30%	  v/v	  ethylene	  glycol.	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only electron transfer but has evidence of gaseous ligand transfer as well. This is the first 
part of a system of oxidoreductase proteins that can generate an electron transport chain 
and possibly shuttle substrates along the same gradient. 
6.2.2: Porphyrin Sequestration
 An equally simple function is akin to that of the Histidine rich protein (HRP) of 
Plasmodium falciparum.3,4 This protein’s sole known function is to bind and sequester free 
heme present in a red blood cell (RBC) when the parasite is present due to the toxic effects 
of free heme that have been discussed.5,6 This protein’s function is amongst the first steps in 
hemozoin formation.7 This simple function has been shown to be possible throughout this 
thesis as the sequestration process of the heme is rapid, discussed in chapters 2 and 3. 
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Figure	   6.3:	   The	   Single	   chain	   protein	   is	   able	   to	   generate	   an	   oxyferrous	   state	  
independently	   at	   each	   heme	   binding	   site.	   Here	   one	   (A)	   and	   two	   (B)	   heme	  
containing	  proteins	  are	  depicted	  going	  from	  oxidized	  (black)	  to	   reduced	  (green)	  
then	  to	  carboxyferrous	  (blue)	  and	  einally,	  the	  oxyferrous	  (red).	  Experiments	  done	  
at	   -­‐15˚C	  in	  CHES	  buffer	  pH	  9	  with	  30%	  v/v	   ethylene	  glycol.	   4.5µM	  protein	  was	  
used	  for	  these	  experiments.	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HRP, like the maquettes is a helical histidine rich protein patterned such that many 
histidines are buried in a hydrophobic patch greatly increasing the affinity of the protein for 
heme. 
6.2.3: Oxygen Binding  
Another function we were able to achieve that is slightly more complex is oxygen 
binding.8,9 The previous work in this lab has established this state before, uncovering  the 
engineering  guidelines needed to form an oxyferrous state,10 and generating  an oxyferrous 
state with a half-life of approximately 2.25 seconds. This oxyferrous state takes advantage 
of the modular nature of heme maquettes. In both sites it forms and decays at the same 
rate, independent of the other heme occupancy (Figure 6.3).
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Figure	  6.4:	  Oxyferrous	  decay	  with	  either	  the	  his-­‐cys	  (green)	  single	  chain	  or	  the	  bis-­‐
his	  (black)	  single	  chain	  protein.	  Despite	  no	  change	  in	  Em,	  the	  oxyferrous	  lifetime	  is	  
extended	   approximately	   four	   times	   its	   original	   length.	   Data	   collected	   in	   CHES	  
buffer	  pH	  9	  at	  15˚C.	  Protein	  at	  10µM.	  Traces	  shown	  are	  the	  decay	  at	  576nm	  (green)	  
and	  574nm	  (black).
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 Using our knowledge of protein assembly, we were able to increase the oxyferrous 
state half-life to approximately 10.2 seconds with the use of an alternate ligation scheme. 
Replacing  one of the histidine residues with a cysteine allows for a large increase in the 
lifetime brought about by a few possible factors (Figure 6.4). The cysteine, being a smaller 
residue than the histidine, leaves more room in the binding  pocket better able to 
accommodate the oxygen. The different geometry can also result in a more stable hydrogen 
bond between the cysteine and oxygen. It is possible that this better oriented bond is able 
to hold the oxygen in place relative to histidine due to the geometry and steric factors. 
Extending  the lifetime of the oxyferrous state is a big  step moving forward. It is the first step 
toward more complex chemistry in the maquette interior. 
6.2.4: Light Harvesting
 The final function being discussed is a rudimentary light harvesting  reaction. This is 
a primary step in photosynthesis, and is performed with chromophores capable of 
absorbing  photons and transferring  the energy to other cofactors that induce more complex 
chemistry.11 In maquettes, I was able to reproduce the initial steps of this process. This 
work follows from that of Dror Noy, however that work chose cofactors empirically, not 
with considerations of their binding  rates or affinities.12 I ligated Zn Mesoporphyrin to a 
modified single-chain protein (H7H112: Sequence Appendix). When this was done we 
were able to generate a FRET pair between that pigment and tryptophan. Figure 6.5 shows 
four different excitation spectra, where we are exciting the chromophore pairs over the 
range shown and collecting  the emissions at 630nm, the fluorescence maximum of Zn-
mesoporphyrin. When the cofactor is excited in this wavelength range there is no 
fluorescence, regardless of the solvent used (DMSO or aqueous CHES Buffer). The protein 
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has some fluorescence emission in this range, as it contains tryptophan, and it is increased 
s ign ifican t ly when 
m i x e d w i t h t h e 
pigment. The increased 
emission comes from 
tryptophan indole ring 
absorbing the energy 
f r o m l i g h t a n d 
transferring  it to the 
Zn-mesoporphyrin via 
FRET. With an R0 value 
of 30Å this is a very 
e ffic ien t reac t ion . 
What is shown here 
are the first steps in 
l i g h t h a r v e s t i n g 
function akin to the 
LHC complex in plants and photosynthetic bacteria. In the future, this could potentially be 
combined with the functions above to generate an entire system wherein a photon can be 
absorbed and transferred to another chromophore photolysing  a CO molecule and opening 
it up for some other function. 
6.3: Discussion
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Figure	   6.5:	   FRET	   between	   tryptophan	   and	   Zn-­‐
Mesoporphyrin	   in	   the	   single	   chain	   protein.	   If	   the	  
chromophore	  is	   excited	  between	  250	  and	  310nm	   there	  is	  
no	   emission	   at	   630nm	   regardless	   of	   the	   solvent	   being	  
CHES	   (blue)	   or	  DMSO	   (green).	   The	   protein	  at	   5µM	  has	   a	  
mild	  emission	  at	   this	  wavelenght	  (red).	  When	  the	  protein	  
is	   excited	  with	  a	  chromophore	  bound	  it	   is	  able	  to	   transfer	  
energy	  over	  and	  the	  total	  emission	  at	  630nm	  is	  increased.	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The work shown in this chapter details some of the various functions achieved in a 
maquette platform. Beginning  with the simple heme binding and slowly working  up to 
more and more complex functions we show the immense versatility of the maquette 
platform and approach working  in knowledge of the most basic physical-chemical 
principles to further our designs.
 The simplest functions of all the ones discussed, the one that underlies all the 
others, is heme binding. This function is well described in the previous chapters but is 
important in nature as well. In addition to the HRP protein in Plasmodium falciparum,3 
there are many other proteins whose sole purpose is to bind and sequester heme.13 The 
hemopexin and ISD proteins, as mentioned in the introduction, are excreted proteins with 
possibly the strongest known affinities for heme.13,14 Due to the low Kd values, it is feasible 
to think that maquettes would be ideal substitutions for this natural function. Their 
assembly mechanism has been discussed here thoroughly. 
 In addition to their function as heme transporting  proteins, these maquettes can 
also be exploited for their electron transfer properties. Maquettes can be tailored to adopt a 
wide range of potentials, through environmental effects or alternate porphyrins. This simple 
function has a vast amount of potential for future use. Biology uses vast electron transport 
chains in two of its most fundamental processes: ATP synthesis and Photosynthesis.15 
maquettes with varying potentials thereby generating an artificial electron transport By 
demonstrating  a relatively simple example of this complex process, maquette show their 
potential for higher order functions, which can be combined with the other functions to 
mimic photosynthesis or respiration activities. 
 The Dutton lab has also gone a long  way toward generating membrane bound 
proteins capable of electron transfer.16 These can be readily incorporated into these 
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electron transport schemes thereby increasing  the functional versatility of this system and 
allowing the generation of a proton gradient across a membrane. Maquettes are also 
capable of incorporating  qunione amino acids,17 with this, the entire function of the bc1 
protein can be recreated in a much more simple system.
 This chapter does more than demonstrate simple functions in a maquette system it 
demonstrates the potential of the maquette system when the underlying  principles are 
known. In a simple scaffold there are a myriad of possibilities that can be attained, and the 
more that is known about the underlying  engineering  required to assemble a specific 
combination of cofactors with protein, the more complex the functions can become. Using 
this work, the transition from the test tube to the cell is not far off. When the holomaquettes 
can assemble spontaneously, a cell can be fed a specific cofactor. This can lead to novel 
functions being carried out by living systems.
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Chapter 7: Conclusions
 This thesis explains the way the maquette approach works. We define operational 
benchmarks from the underlying  physical chemistry, and using that we are able to 
incorporate novel functions into the maquette framework. Understanding  how the protein 
affects the assembly and reactivity of various cofactors is more important now as the new 
generation of maquettes, and functions becomes more complex. 
This ground up approach starts with the most basic aspect of function: assembly. 
Up to now, the lab has taken advantage of the simple system and spontaneous assembly. 
Optimizing this process is key for a multitude of reasons. If maquettes are to be inserted 
into cells they must be able to compete with the natural and present proteins when it 
comes to binding  cofactors. Alternatively, if cofactors are to be added to cells they must be 
able to insert themselves into the machinery present. Maquettes must be capable of quickly 
assembling  in a test tube so that their assembly in vivo can be optimized and devoid of side 
reactions. Assembly is also relevant for industrial applications. It is not profitable for a 
company to have a holoprotein that spontaneously assembles over the course of weeks or 
requires chaperones. A much more practical option is one where the protein can 
spontaneously assemble on the seconds timescale and is robust enough to be transported 
to distant locations, synthetic blood is one example. If this could be developed rapidly and 
transported long  distances it could provide medical aid to people in need all over the 
world. 
Chapters 3 is an investigation of that and how assembly is modified through 
changes to the protein sequence. This has uncovered different types of kinetic limitations 
enforced through the protein’s gross structural characterisitcs, not by individual amino 
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acids. Both entropic and enthalpic barriers were uncovered that have been seen before. 
We have shown that proteins must be monomeric in solution as to avoid problems linked 
to preassembly. These problems are mainly caused by diffusion and protein rearrangement 
and are defined as an entropic barrier. We also observed that a densely packed core is also 
a drawback, this one being  enthalpic in nature. This knowledge allows for future designs to 
be enhanced by being  able to pull out what is kinetically inhibiting  them. The Eyring plot 
of figure 3.6  can be thought of as a diagnostic tool, one that can be utilized when there are 
problems binding. Once the barrier has been uncovered, it is a simple matter of either 
making the core less stable or adding a structural element. 
Chapter 4 deals with the other half of this reaction: The cofactor. In this section we 
see various different factors that can impede its binding. Though not necessarily due to 
solubility, the rate of assembly is highly correlated with the log-P value, providing  a rough 
guide to aid in cofactor selection. This is not the only mitigating  factor, the structure of the 
tetrapyrrole ring  itself, and the metal center also have noticeable effects on the assembly 
rate. These principles could be a boon to future designers. If assembly is slow, but the 
protein appears optimized, the cofactor may not be suitable for rapid assembly. Looking at 
its log-P value can test this hypothesis, which can be modified, for example with a 
newkome dendrimer increasing the rate. 
It is hoped that with this knowledge the future designs will not be limited with 
assembly steps before they are ready to assume their function. 
Though assembly is important, making sure the protein sequence will have a 
desired effect on the reactivity is equally important. All throughout nature there are 
hemoproteins with a wide range of potentials.1 Bringing maquettes into the cell and having 
them take part in biology means they will need to have an equally diverse range of 
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potentials. The maquette approach also allows a high level of control over distances and 
the scaffold’s high tolerance to mutations help  to create a docking  site for other proteins. 
This could lead to the beginning of artificial electron transport chains. 
Chapter 5 investigates the electrochemistry thoroughly, and we examine four areas 
where the maquette can be applied such that a heme B cofactor has a wide range of 
potentials. The most intense range came from changing  the cofactor itself. Attaching 
electron-withdrawing  groups to the porphyrin directly drove the potential up approximately 
370mV. Other methods of changing the environment, or ligations also had a significant 
effect, shifting the Em by as many as 140mV. 
As in nature, the maquette approach is not bound to one set of potential shifting 
mutations. Various ones can be mixed together to generate high potential heme cofactors 
spanning the range of natural enzymes. This work will be integral to these designs, laying 
the groundwork for the future of raised heme midpoint potentials. If maquettes are to be 
introduced into living systems, it is these principles that will influence their sequence. 
By addressing  the underlying  physical chemistry we are able to engineer functions 
into a maquette system. Being  able to both bind a series of cofactors and modulate their 
potentials was the first step in creating  the first pair of maquettes capable of electron 
transfer. Though a small first step, this concept is key to the beginning  of larger arrays that 
can eventually mimic the electron transport properties of the respiration enzymes in nature. 
In fact progress has already been made by Fry, Discher et. al. putting  maquettes into 
membranes and transporting electrons across it.2 Coupled with the progress made with 
Flavins and quinones the maquette approach can these pieces together and generate a 
completely synthetic proton motive force. 
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Light harvesting  is another area where the maquette approach could have a major 
impact. Aided with the work here describing cofactor selection and protein requirements, a 
light harvesting and light-energy transfer maquette was produced. This maquette, also 
demonstrates a proof of principle concept that this complex function is possible on a much 
smaller and simpler scale. With knowledge of chromophore attributes, expanding  the range 
of light that can be used is the next step to generating  complex light activated charge 
separation and from there complex, high oxidative chemistry, like that seen in oxygen 
generation. Goutham Kodali has already begun adding  a wide array of chromophores 
extending the range of captured solar light from what is seen in nature. 
Though simple, heme binding  and sequestration plays a vital role in cellular 
viability. As mentioned previously, free heme is toxic and free light harvesting  tetrapyrroles 
also can be potentially hazardous to the cell.3,4 The function of binding  thus plays a vital 
role keeping  ROS levels low. Indeed many organisms have complex systems that do 
nothing  but simply bind heme and sequester it until it is needed later.5 In those terms the 
maquettes are already poised to play a role in the cell, protecting  from ROS and aggregated 
porphyrins. The single chain maquette is only limited in its heme binding  by the cofactor. 
In the cell free heme is kept to a minimum, and therefore heme aggregation is a minor 
issue. The assembly would be limited by diffusion alone. 
Finally this work has also improved the function of oxygen binding. By adding  a 
cysteine residue to the heme-binding site the oxyferrous lifetime was extended 
approximately 5 times its original. This lifetime-extension has many important applications 
like synthetic blood as mentioned above. This work establishing  increased Em values could 
also have a substantial impact in this function as well, and Molly Sheehan is working 
toward that end.
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This thesis uncovers the physical chemistry key to many diverse oxidoreductase 
functions. We have described the binding  kinetics filling out Scheme 3.1. The barriers can 
be clearly uncovered and the protein can be modified to avoid them. The cofactor effects 
have also been characterized. We have now a deeper understanding  of holoprotein 
assembly, and can better modify designs in the future to reflect that. We have also 
expanded the range of electrochemical potentials in maquettes, and have paved a clear 
path toward generating artificial electron transport chains. Future maquette work will be 
able to expand the functional repertoire in these systems better explaining  natural enzymes 
as well as putting synthetic ones to use for the benefit of society.
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Appendix 1: Materials And Methods
A.1: Materials
 All materials were purchased from Sigma-Aldrich unless otherwise noted. Solvents 
were purchased from Fisher Scientific. 
A.2: Porphyrins
 All porphyrins were purchased from Frontier Scientific unless otherwise noted. 
They were dissolved in DMSO and their concentration was determined by mass with a 
couple of exceptions. Heme B, Fe-mesoporphyrin, and Fe-Deuteroporphyrin had their 
concentrations measured by the pyridine hemochrome assay, utilizing  the extinction 
coefficient at 556nm as described here.1 Of a solution of 40% pyridine with 100mM 
NaOH, 997uL was placed into a cuvette. To this 1uL of a heme stock was added as well as 
2uL of a K3Fe(CN)6 to ensure the sample was fully oxidized. After full oxidation was 
confirmed, a spatula tip containing  sodium dithionite was added to the cuvette. The 
mixture was given 10 seconds to reduce, and a spectrum was taken. This was done with at 
least 4 different volumes varying only the heme and pyridine-mixture volumes, not the 
K3Fe(CN)6. The absorbance of 556nm – 540nm was monitored and plotted as a function of 
heme volume added. This was fit to a line with a slope of (34.7 x [heme]) and a intercept 
set to zero. This line is a simple use of beer’s law coupling  the absorbance to the 
concentration. The value of specific extinction coefficients can be found in the spectral 
appendix. 
106  
      
107
Heme-a was purified and its mass was quantified as described here.2 Bruce R. 
Lichtenstein synthesized 2,6-Dinitrile porphyrin. Its synthesis protocols can be found is his 
PhD thesis. Its concentration was determined by weight and its purity is unknown.3
A.3 Proteins
The proteins used in this paper were obtained as follows.  The gene for the protein 
was ordered from DNA2.0.  The construct contained a His-tag, a linker, and then the 
protein of interest.  No fusion was used.  Upon delivery of the gene the DNA was 
resuspended in TE buffer and transformed into both DH5α and BL-21 strain E. coli cells. 
For expression, the BL-21 cells were grown in TB media until the OD600 was at 0.6  AU 
then over-expression was induced by addition of IPTG to a concentration 1mM.  The cells 
over-expressed the protein for 4.5 hours and then were spun down to a pellet.  The pellet 
was then resuspended in lysis buffer (300mM NaCl, 50mM NaH2PO4, 10mM Imidazole, 
pH 7) and sonicated at an amplitude of 90 (5 times, 20 seconds each time).  The lysate was 
spun down for 1hour at 20,000g.  The supernatant was then run through a GE-Histrap 
column.  The eluate was TEV cleaved and rerun on the column.  The flowthrough of this 
second column was dialyzed into CHES buffer (20mM CHES, 150mM KCl, pH 9).4
 Its concentration was determined by the absorbance at 280nm using  an extinction 
coefficient of 22,500 M-1 cm-1. The extinction coefficient was determined with the 
ProtParam software on the ExPASy website (http://web.expasy.org/protparam/). 
 Where the proteins could not be ordered as is and mutagenesis had to be done 
primers were ordered from Integrated DNA Technologies (IDT)  and dissolved to a level of 
10uM. Using this stock, 1µL was added to a solution containing  the plasmid (obtained from 
either DNA2.0 or from a previous lab member). 1µL of this primer was mixed with 5ng  of 
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template DNA, polymerase mix to 1X (2X master mix: 4µL 5X Phusion buffer, 0.5µL 10mM 
dNTP, 0.2µL Phusion Hot Start, 0.2µL 50mM MgCl2, 5.1µL Milli-Q water), and Milli-Q 
water to obtain a 10µL final volume. This was subject to a PCR cycle of 98˚C for 30 
seconds, followed by 98˚C for 10 seconds, Annealing  temperature for 30 seconds, 72˚C for 
the extension time (repeat for 15 cycles), followed by a final extension step at 72˚C. When 
this was completed, the reaction was held at 4˚C until needed. This DNA was then 
transformed as discussed above and the protein was purified as discussed pending 
sequencing. 
 Certain proteins were unable to be made in E. coli. These were prepared at a 
0.1mmol scale on a CEM Liberty microwave peptide synthesizer using  standard FMOC/tBu 
protection protocols.5  Amino acids were purchased from Nova Biochem.  The side chain 
protecting  groups were as follows: Cys (trt), Lys (Boc), His (Boc), and Asp/Glu (OtBu).  After 
synthesis the protein was cleaved from the resin by incubating  it with a mixture of 
trifluoroacetic acid (TFA), ethanedithiol, Anisole and thioanisole in a 9: 0.2 : 0.5 : 0.3 ratio 
for two and a half hours protected from light.  The crude product then had excess reagent 
removed in vacuo and was subsequently precipitated with methyl,t-butyl ether.  The 
peptide was then purified by reverse phase HPLC using a C18 column and a linear gradient 
of Acetonitrile with 0.1% (v/v) TFA in water with 0.1% (v/v)  TFA.   The products were 
verified with MALDI Mass spectroscopy using  a 2-(4'-Hydroxybenzeneazo)benzoic acid 
(HABA) matrix.
A.4: Partition Coefficients
 Partition coefficients were determined by dissolving  the chromophore in 1-octanol 
and taking  a spectrum to make sure there was no aggregation.6  This was then mixed with 
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an equal volume water, vortexed, and allowed to sit for one hour at room temperature. 
After this hour the spectra of the octanol layer was taken again.  The soret absorbance was 
taken again and subtracted from the pre-mixed soret, this value is counted as the 
concentration of porphyrin in the water layer. The two values were analyzed in the 
following way:
Log [Porphyrin]octanol layer/ [Porphyrin]water layer
This value is known as the Log-P value, or partition coefficient. The concentration of 
porphyrin in the aqueous layer was calculated as the concentration in Octanol before 
minus the concentration in octanol after mixing and incubation. This is described below
[Porphyrin]aqueous layer = [Porphyrin]octanol before mixing - [Porphyrin]octanol after mixing and incubation
A.5: Rates
Millisecond scale time measurements were made on an OLIS RSM 1000 stopped 
flow spectrophotometer.  The tetrapyrrole and protein were added to separate syringes and 
shot together monitoring  the absorbance (typically from 386nm to 611nm unless otherwise 
noted).  The apparatus had a Fischer-Scientific IsoTemp 3031 water bath attached, allowing 
for temperature control.  The experiments in this thesis were determined at variable degrees 
Celsius, noted in the specific experiments.  Multiple spectroscopic species were 
determined using  SVD analysis included in the OLIS Globalworks software.  Individual 
wavelengths were identified by eye for further kinetic analysis.
The samples had to be loaded onto the machine already in buffer. Solutions of 
DMSO were not used for these experiments.
Data Fitting  for the Eyring  plots is as follows: The rates were determined by first 
fitting the initial slopes from 0 up to 20msec. The slope was then divided by an extinction 
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coefficient of 110,000 M-1 cm-1 to obtain the value in the proper units.  The rates were then 
fit to the following equation to obtain the pseudo-thermodynamic parameters of the 
transition state obtained from Transition State Theory:7
k = κ (kBT/h) e(ΔS‡/R) e (-ΔH‡/RT) 
Where k is the initial rate for the raction. kB is the boltzman constant, and h is plank’s 
constant.  T is the temperature in Kelvin. R is the gas constant in units of cal K-1 mol-1. ∆S‡ 
and ∆H‡ are the entropy and enthalpy differences between the ground reactant state and 
the transition state respectively. κ is transmission coefficient, a term used to describe the 
amount of reactions that go to the transtition state and proceed back to reactants, here it is 
assumed to be one, indicating that all transition states proceed to a product and do not 
dissociate back into reactants.
A.6: Spectra 
Protein solutions were prepared in CHES buffer. Binding  was monitored by UV/Vis Soret 
absorbance on a Varian Cary-50 spectrophotometer at room temperature in a 1 cm path 
quartz cuvette. Secondary structure was monitored by CD spectroscopy (Aviv Model 410) 
with a 1 mm path quartz cuvette. Thermal denaturation monitored the ellipticity at 222 nm 
every 5˚C from 5˚C to 95˚C after 15 minutes of equilibration. Melting  temperatures were 
calculated using a Boltzmann equation with one term for each observed transition.
A6.1: Fluorescence Spectra
 Fluorescent data was collected on Florolog  Jobin-Yvon fluorometer. A standard 
temperature of 25˚C was held constant with a Fischer-Scientific IsoTemp 3031 water bath. 
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A 1cm path-length cuvette, graded for fluorescent work was used. Experiments were 
performed in CHES buffer pH 9. 
A.7: Kd Titrations
 Affinity titration experiments were performed with low concentration of protein 
typically in the nanomolar range. Porphyrin was added in 0.1 equivalents and a spectrum 
was taken. These were fit to the tight binding equation:4
where A is the absorbance at the Soret band, Htot is the total heme concentration, Ptot is the 
total protein concentration, Kd is the affinity constant, ∈bound is the extinction coefficient of 
bound porphyrin, and ∈free is the extinction coefficient of free porphyrin. These were 
performed in either a 1cm or 10cm pathlenght cuvette. The cuvette volumes of each are 
3mL or 30mL respectively. 
A.8: Em Titrations
 Redox titrations were performed in combination with UV/Vis monitoring, adapted 
from Dutton et. al..8,9  Samples of typically 5-25µM were monitored electrochemically by a 
calomel electrode purchased from Radiometer analytical.  The change from oxidized to 
reduced was monitored by the change in absorbance at the q-band region of the bis-his 
ligated porphyrin.  These titrations were done anaerobically with a constant stream of Ar 
being  blown over the top of the sample.  The Eh was modulated by 1-3µL injections of a 
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freshly prepared sodium dithionite solution when trying  to lower the potential or a 
potassium ferricyanide solution when trying  to increase the potential.  The following  redox 
mediatiors were used: Anthra-quinone-2-sulfonate (20µM), Benzly Viologen (10µM), 
Methyl Viologen (10µM),Sulfanilamide (10µM), Indigo trisulfonate (10µM), Phenazine 
(10µM), Pyocyanin (10µM), and Hydroxy-Napthquinone (10µM).
 The apparatus used was a specialized redox-cuvette designed by Dutton et. al. and 
is described here.8
 The data was analyzed the same as Gibney et al 1998 Biochemistry. The 
absorbance value of the reduced peak (corrected for baseline shifts)  was plotted against 
voltage and fit to the Nerst equation described in the introduction and displayed below:10
 
Where Ecell is the reduction potential, E˚cell is the standard potential, R is the gas constant, T 
is the temperature in Kelvin, z is the number of moles of electrons involved in the half cell 
reaction, F is Faraday’s constant (96485 C mol-1), [Red] is the concentration of reduced 
components, and [Ox] is the concentration of oxidized components.
 This equation is converted to the following when used for fitting:
1
10 
E
h
-E
m
[RT/nF]
+ 1
Fraction Reduced =
When two midpoint potentials are present, the equation can be expanded to account for 
that. 
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Where the fraction reduced is a combination of the sum of the concentrations of each 
species.
A.8.1: Spectral-Electrochemistry Titrations
 Spectroelectrochemical titrations were carried out with a platinum working 
electrode, gold counter wire, and a Ag/AgCl reference electrode. A CH Instruments  (Austin 
Texas USA)  Electrochemical workstation was used with the CH Instruments interface 
program version 9.07. In a cuvette with a 0.1cm path-length, 200µM single chain protein 
with tetracarboxyphenylporphyrin was added, dissolved in 20mM CHES 150mM KCl buffer 
pH 9. Mediators used were: Anthra-quinone-2-sulfonate (100µM), Benzly Viologen (50µM), 
Methyl Viologen (50µM),Sulfanilamide (50µM), Indigo trisulfonate (50µM), Phenazine 
(50µM), Pyocyanin (50µM), and Hydroxy-Napthquinone (50µM)  The electrodes were 
placed in the solution and the cuvette was sealed with parafilm. A potential was set by the 
computer and the current was monitored. When the current reached zero, a spectra was 
taken. This was repeated in 20mV steps from -450mV up to -150mV. This was done 
multiple times (2 oxidative, and 2 reductive) to see if there was any hysteresis. Afterward, 
the absorbance value of 535nm-517nm was plotted against voltage and fit to the nernst 
equation as above yielding an Em value. 
A.9: Greater Than Millisecond Rate Values
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 Zinc-protoporphyrin IX (ZnPPIX)  deaggregation experiments were performed on a 
Varian Cary-500 spectrophotometer.  ZnPPIX was dissolved in aqueous buffer at a 
concentration of 24µM and allowed to crash out of solution overnight.  This solution of 
aggregated chromophore was inverted four-five times to equally disperse the aggregates 
and 500µL was removed and added to a cuvette.  To this cuvette 500µL of a 6µM protein 
was added and a spectrum was taken every 5 minutes for two hours.
A.10: Intra-maquette Electron Transfer
 Electron transfer was first done on a OLIS-stopped flow apparatus as described 
above. The temperature was controlled with a Fischer-Scientific IsoTemp 3031 water bath. 
In each syringe was added the single chain protein with either DADPIX or heme B. These 
were degassed in the syringe for approximately one hour. To the degassed heme syringe, 
dithionite was added and monitored at 314nm to ensure no excess reductant was present, 
and the heme was monitored at 425nm to ensure it was reduced. If too much reductant 
was present, FeCN was added to remove it. When it was reduced, and no excess reductant 
could be observed, the stopped flow was fired mixing  the samples together. Electron 
transfer was monitored in the Soret region. 
A.11: Low Temperature Electron Transfer
 For the low temperature electron transfer a 3mL cuvette was used. 1.5mL of 5µM 
heme in the single chain protein (CHES buffer pH 9, 30% v/v ethylene glycol)  was added 
to this protein and degassed under Ar flow for 1 hour. This was reduced until a peak at 
314nm was detected. The temperature was lowered to -10˚C. At this point CO gas was 
bubbled through until no reduced heme could be detected, as all had been converted to 
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CO-ferrous heme. Oxygen was then bubbled through until no dithionite could be deteced 
at 314nm. At this point, 1.5mL (CHES buffer pH 9, 30% v/v ethylene glycol)  of 5µM 
DADPIX-single chain protein was added. A spectrum was taken and the entire sample was 
degassed with Ar gas for 1.5 hours. At this point, a projection lamp was turned on for 
approximately ten seconds to flash off the CO and a spectrum was immediately taken to 
observe any electron transfer. The flashes and spectra were repeated as necessary until no 
more change was detected.
A.12: Oxygen Binding
 Oxygen binding  was performed on an Varian Cary 50 as described above. 5µM 
protein with one or two heme cofactors (CHES buffer pH 9, 30% v/v ethylene glycol) was 
added to a 3mL cuvette and degassed under Ar flow for 1 hour. Following  this, dithionite 
was added until the protein appeared fully reduced and no evidence of oxidized protein 
could be detected. At this point CO gas was bubbled through until all the reduced protein 
appeared converted to CO-ferrous. When the reduced heme was bound to CO, oxygen gas 
was bubbled through to the point that no dithionite could be detected, and then for 0.5 
hours more. A projection lamp was then used to flash off the CO in the presence of 
oxygen. Spectra were taken until no change could be detected.11
A.13: Oxygen Binding And Decay Rates
 Oxygen binding was performed on an OLIS stopped flow as described above. In 
one syringe was a solution of CHES buffer pH 9 saturated with oxygen. Saturation was 
achieved by bubbling  O2 gas through for approximately 1 hour. In the other syringe was 
5µM protein was added and reduced with dithionite until the protein appeared fully 
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reduced. The absorbance at 314nm was monitored to ensure no excess reductant was 
present. These two syringe contents were shot against each other at 15˚C and the 
absorbance between 386 and 611nm was collected. The data was analyzed by monitoring 
the absorbance over time at 547nm for bis-his oxyferrous, and 576nm for his-cys 
oxyferrous. The lifetimes were determined by fitting  the decay to simple first order 
exponential kinetics.11
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Appendix 2: Sequence Appendix
The following  sequences were used throughout this thesis. This section will provide the 
sequence, appropriate references, and relevant background information.
H10A24 or Unstructured Homotetramer:
CGGGELWKLHEELLKKFEELLKLAEERLKKL
This sequence was originally developed by Brian Gibney and published in various papers.
1-3 It binds two b-type hemes per four helices and has split midpoint potentials at -230mV 
and -148mV.  This was chosen to be included in this work as it has been thoroughly 
characterized structurally and electrochemically, providing a maquette example of a 
protein with a split potential stemming  from heme proximity. Though one helix, the N-
terminal Cysteine residue allows it to form a dimerized helix-loop-helix motif
BB or the Structured Homotetramer:
CGGGEIWKLHEEFLKKFEELLKLHEERLKKM
First developed and published by Steve Huang, this protein was chosen due to its stable 
apo structure and low-resolution holo-state.4,5 I measured the Kd value as well as the 
binding  rates. No midpoint titration data of this protein is included in this work. Like 
H10A24, this protein is a single helix that forms a helix-loop-helix motif through its N-
terminal cys residue
C38S or the Homodimer
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQHEDALQKFEDALNQFEDLKQL
First developed by Ronald Koder, this protein was chosen for this paper due to its 
resemblance to the tethered-homodimer without the tether. I attempted ot measure the Kd 
value however at the concentrations required the protein was not dimerized sufficiently. 
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HP7 or Tethered Homodimer
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGCGSGG
EIWKQHEDALQKFEDALNQFEDLKQL
Also developed by Ronald Koder, this protein was used as the first example of an 
oxyferrous state in an artificial framework.6,7 It was included in this work as it is an dimeric 
protein that functions as a monomer making it a key example for binding  kinetics.  Its low 
and previously established midpoint potential and simple sequence provided a scaffold for 
probing  the effects of modifications on the Em value. It also was the basis for the oxygen 
binding work attempted here. 
BT6 or the Single Chain
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQHEDALQKFEDALNQFEDLKQL
Designed as a thesis project by Tammer Farid and Bruce Lichtenstein, this protein is based 
on HP7 however with the disulfide removed and a peptide linker in its place.8 This was 
chosen as the final step of this sequence family in rate studies. It has the least amount of 
symmetry allowing  for single amino acid mutations and was subsequently used as a basis 
for further designs 
Cytochrome b562
ADLEDNMETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDF
RHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYHQKYR
A single chain four-helix bundle protein found in E. coli thought to be used in electron 
transfer reactions.9-11 This protein was chosen, as it is a well-known and studied heme-
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binding  protein, to provide a comparison of natural proteins to maquettes. It has a 6nm Kd 
value and a +189mV Em value.12 
BT6-F or SC-F
GEIWKQFEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQFEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQFEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQFEDALQKFEDALNQFEDLKQL
This protein was designed by Tammer Farid and used as a non-heme-binding  control for 
various studies here.
GLBin-Heme
GEIWKQHEDALQKFEEALNQFEDLKQLGGSGKGSGG
EIKRQHEDALRKFEEALKRFEDKKQKGGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQLGGSGKGSGG
EIKRQHEDALRKFEEALKRFEDKKQK
Goutham Kodali and myself designed this protein. I used it as a test of charge patterning  on 
the Em values of heme in maquettes. 
Positive mutant (POS-mut)
GEIKRQHEDALRKFEEALKRFEDKKQKGGSGKGSGG
EIWKRHEDALRKFEEALKRFEDKKQKGGSGKGSGG
EIWKRHEDALRKFEEALKRFEDKKQKGGSGKGSGG 
EIKQRHEDALRKFEEALKRFEDKKQK
I designed this protein as a tool to further study the effect of charge patterning on the heme 
Em value. 
F56HA3
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGCGSGG
EIWKQFADALQKFADALNQHADLKQL
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This protein, a variant of HP7, was used in this work to show the effect of charge patterning 
on Em values. Instead of adding positive charges, this simply has negative charges removed. 
HP7A6
GEIWKQHADALQKFADALNQFADLKQLGGSGCGSGG
EIWKQHADALQKFADALNQFADLKQL
This protein was designed for the purposes of E shifts and gaseous ligand binding control. 
E8A
GEIWKQHADALQKFEDALNQFEDLKQLGGSGCGSGG
EIWKQHEDALQKFEDALNQFEDLKQL
Designed to generate a midpoint potential shift albeit unsuccessfully. Appears to have a 
similar affinity for heme as HP7
E57A
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGCGSGG
EIWKQHEDALQKFEDALNQFADLKQL
Like E8A, this protein was designed to generate a Em shift, though also unsuccessful. 
Appears to have a similar affinity for heme as HP7
GLBin-K59,112L
GEIWKQHEDALQKFEEALNQFEDLKQLGGSGKGSGG
EIKRQHEDALRKFEEALKRFEDLKQKGGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQLGGSGKGSGG
EIKRQHEDALRKFEEALKRFEDLKQK
This protein designed by Goutham Kodali was used to elucidate the change of Em and Kd 
by the change in a buried Lysine. 
BT6-CYP
GEIWKQCEDALQKFEDALNQFEDLKQLGGSGSGSGG
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EIWKQAEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQL
This protein was designed by Goutham Kodali and used to show the effect of ligation 
changes on the Em of a heme.
BT6-HisCys
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQCEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQL
This protein was designed by Goutham Kodali and used to show the effect of ligation 
changes on the Em of a heme.
HP7-Offset
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGCGSGG
EIWKQFEDALQKHEDALNQFEDLKQL
This protein was designed by me and used to move the heme around inside the bundle to 
generate a split midpoint potential
BT6-H7-112
GEIWKQHEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQAEDALQKFEDALNQFEDLKQLGGSGSGSGG
EIWKQHEDALQKFEDALNQFEDLKQL
This protein was used for the light capture reactions. It was chosen over BT6 proper for its 
lack of ability to bind heme B as there are no bis-his binding sites.
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Appendix 3: Spectral Appendix
A3.1: Heme
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Figure	  A3.1:	  (A)	  Heme	  bound	  to	  protein	  in	  its	  oxidized	  (black),	  reduced	  (green)	  and	  
carbon-­‐monoxide	  (CO)	  bound	  state	  (blue).	  (B)	  Heme	  in	  Dimethyl	  Sulfoxide	  (DMSO)	  
and	  in	  20mM	  CHES	  150mM	  KCl	  buffer.	  Wavelength	  in	  nm.	  Absorbance	  Normalized	  
to	  Soret	  peak.
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Figure	  A3.2:	  Spectra	  of	  Heme	  at	  3.5µM	  in	  the	  b562	  protein
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A3.2: Alternate Fe-porphyrin Kinetics
Figure	  A3.3:	  (A)	  Free	  heme	  B	  in	  solution	  (black),	  heme	  bound	  to	  protein	  (green),	  and	  
the	  difference	   spectrum	  (blue).	   (B)	  4	   second	  trace	   of	  heme	  B	   assembling	  with	  the	  
single	   chain	  protein.	   (C)	  Heme	   B	   in	  octanol	   (black)	  and	   octanol	   after	  mixing	   with	  
20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9.	   (D)	   Chemical	   structure	   of	   Heme	   B.	   All	  
wavelenghts	  are	  in	  nm.	  The	  extinction	  coefeicient	  at	  412nm	  is	  109,700	  M-­‐1cm-­‐1.1
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Figure	  A3.4:	   (A)	  Free	  Mesoporphyrin	  in	  solution	  (black),	  Mesoporphyrin	  bound	  to	  
protein	   (green),	   and	   the	   difference	   spectrum	   (blue).	   (B)	   4	   second	   trace	   of	  
Mesoporphyrin	   assembling	   with	   the	   single	   chain	   protein.	   (C)	   Mesoporphyrin	   in	  
octanol	  (black)	  and	  octanol	  after	  mixing	  with	  20mM	  CHES	  150mM	  KCl	  buffer	  pH	  9.	  
(D)	  Chemical	  structure	  of	  Mesoporphyrin.	  All	  wavelenghts	  are	  in	  nm.	  The	  extinction	  
coefeicient	  at	  405nm	  is	  115,000	  M-­‐1cm-­‐1.2
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Figure	   A3.5:	   (A)	   Free	   Deuteroporphyrin	   in	   solution	   (black),	   Deuteroporphyrin	  
bound	  to	  protein	  (green),	  and	  the	  difference	  spectrum	  (blue).	   (B)	  4	  second	  trace	  of	  
Deuteroporphyrin	  assembling	  with	   the	  single	   chain	  protein.	   (C)	  Deuteroporphyrin	  
in	  octanol	  (black)	  and	  octanol	  after	  mixing	  with	  20mM	  CHES	  150mM	  KCl	  buffer	  pH	  
9.	   (D)	   Chemical	   structure	   of	   Deuteroporphyrin.	   All	   wavelenghts	   are	   in	   nm.	   The	  
extinction	  coefeicient	  at	  403nm	  is	  122,000	  M-­‐1cm-­‐1.2
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Figure	  A3.6:	  (A)	  Free	  Iso	  Hematoporphyrin	  in	  solution	  (black),	  Iso	  Hematoporphyrin	  
bound	  to	  protein	  (green),	  and	  the	  difference	  spectrum	  (blue).	   (B)	  4	  second	  trace	  of	  
Iso	   Hematoporphyrin	   assembling	   with	   the	   single	   chain	   protein.	   (C)	   Iso	  
Hematoporphyrin	   in	   octanol	   (black)	   and	   octanol	   after	   mixing	   with	   20mM	   CHES	  
150mM	   KCl	   buffer	   pH	   9.	   (D)	   Chemical	   structure	   of	   Iso	   Hematoporphyrin.	   All	  
wavelenghts	  are	  in	  nm.	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Figure	   A3.7:	   (A)	   Free	   Diacetyl	   Deuteroporphyrin	   in	   solution	   (black),	   Diacetyl	  
Deuteroporphyrin	  bound	  to	  protein	  (green),	  and	  the	  difference	  spectrum	  (blue).	  (B)	  
4	   second	   trace	   of	   Diacetyl	   Deuteroporphyrin	   assembling	   with	   the	   single	   chain	  
protein.	   (C)	  Diacetyl	   Deuteroporphyrin	   in	  octanol	   (black)	  and	  octanol	   after	  mixing	  
with	   20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9.	   (D)	   Chemical	   structure	   of	   Diacetyl	  
Deuteroporphyrin.	  All	  wavelenghts	  are	  in	  nm.	  The	  extinction	  coefeicient	  at	  426nm	  is	  
89,000	  M-­‐1cm-­‐1.3
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Figure	   A3.8:	   (A)	   Free	   Tetracarboxyphenylporphyrin	   in	   solution	   (black),	  
Tetracarboxyphenylporphyrin	   bound	   to	   protein	   (green),	   and	   the	   difference	  
spectrum	   (blue).	   (B)	   4	   second	   trace	   of	   Tetracarboxyphenylporphyrin	   assembling	  
with	  the	   single	   chain	   protein.	   (C)	  Tetracarboxyphenylporphyrin	   in	   octanol	   (black)	  
and	  octanol	   after	  mixing	  with	  20mM	  CHES	   150mM	  KCl	   buffer	  pH	  9.	   (D)	  Chemical	  
structure	  of	  Tetracarboxyphenylporphyrin.	  All	  wavelenghts	  are	  in	  nm.	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Figure	   A3.9:	   (A)	   Free	   2,6-­‐Dinitrileporphyrin	   in	   solution	   (black),	   2,6-­‐
Dinitrileporphyrin	  bound	  to	  protein	  (green),	  and	  the	  difference	  spectrum	  (blue).	  (B)	  
4	  second	   trace	   of	  2,6-­‐Dinitrileporphyrin	  assembling	  with	   the	   single	  chain	  protein.	  
(C)	   2,6-­‐Dinitrileporphyrin	   in	  octanol	   (black)	  and	  octanol	   after	  mixing	  with	  20mM	  
CHES	  150mM	  KCl	  buffer	  pH	  9.	   (D)	  Chemical	  structure	  of	  2,6-­‐Dinitrileporphyrin.	  All	  
wavelenghts	  are	  in	  nm.	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Figure	   A3.10:	   (A)	  Free	  Etioporphyrin	   in	   solution	   (black),	   Etioporphyrin	  bound	   to	  
protein	   (green),	   and	   the	   difference	   spectrum	   (blue).	   (B)	   4	   second	   trace	   of	  
Etioporphyrin	  assembling	  with	  the	  single	  chain	  protein.	  (C)	  Etioporphyrin	  in	  octanol	  
(black)	   and	   octanol	   after	   mixing	   with	   20mM	   CHES	   150mM	  KCl	   buffer	   pH	   9.	   (D)	  
Chemical	   structure	   of	   Etioporphyrin.	   All	   wavelenghts	   are	   in	   nm.	   The	   extinction	  
coefeicient	  at	  395nm	  is	  98,000	  M-­‐1cm-­‐1.4
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Figure	   A3.11:	   (A)	   Free	   Protoporphyrin	   IX	   Dimethyl	   Ester	   in	   solution	   (black),	  
Protoporphyrin	   IX	   Dimethyl	   Ester	   bound	   to	   protein	   (green),	   and	   the	   difference	  
spectrum	  (blue).	  (B)	  4	  second	  trace	  of	  Protoporphyrin	  IX	  Dimethyl	  Ester	  assembling	  
with	   the	   single	   chain	   protein.	   (C)	   Protoporphyrin	   IX	   Dimethyl	   Ester	   in	   octanol	  
(black)	   and	   octanol	   after	   mixing	   with	   20mM	   CHES	   150mM	  KCl	   buffer	   pH	   9.	   (D)	  
Chemical	  structure	  of	  Protoporphyrin	  IX	  Dimethyl	  Ester.	  All	  wavelenghts	  are	  in	  nm.	  
The	  extinction	  coefeicient	  was	  assumed	  to	  be	  equal	  to	  that	  of	  Heme	  B.
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A3.3: Alternate Fe-porphyrin Redox Titrations
Figure	  A3.12:	  (A)	  Free	  Heme	  A	  in	  solution	  (black),	  Heme	  A	  bound	  to	  protein	  (green),	  
and	  the	  difference	  spectrum	  (blue).	   (B)	  4	  second	  trace	  of	  Heme	  A	  assembling	  with	  
the	  single	  chain	  protein.	  (C)	  Heme	  A	  in	  octanol	  (black)	  and	  octanol	  after	  mixing	  with	  
20mM	   CHES	   150mM	   KCl	   buffer	   pH	   9.	   (D)	   Chemical	   structure	   of	   Heme	   A.	   All	  
wavelenghts	  are	  in	  nm.	  The	  extinction	  coefeicient	  at	  420nm	  is	  131,000	  M-­‐1cm-­‐1.5
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Figure	  A3.13:	  (A)	  Mesoporphyrin	  redox	  titration	  and	  (B)	  Oxidized	  (black)	  and	  
reduced	  (green)	  spectra.	  Soret	  at	  411nm	  and	  Isosbestic	  point	  at	  404nm
Figure	  A3.14:	  (A)	  Deuteroporphyrin	  redox	  titration	  and	  (B)	  Oxidized	  (black)	  and	  
reduced	  (green)	  spectra.	  Fraction	  reduced	  calculated	  from	  ratio	  of	  546nm/531nm
134  
      
      
A B
135
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
-600 -400 -200 0 200 400
Ab
so
rb
an
ce
 (S
or
et
 - 
Is
os
be
st
ic
)
Eh (mV)
0.5
1
1.5
2
350 400 450 500 550
Ab
so
rb
an
ce
Wavelength
A B
-1
-0.5
0
0.5
1
1.5
-600 -400 -200 0 200 400
Ab
so
rb
an
ce
 (S
or
et
 - 
Is
os
be
st
ic
)
Eh (mV)
0.4
0.8
1.2
1.6
2
2.4
2.8
300 350 400 450 500 550 600 650 700
Ab
so
rb
an
ce
Wavelength
A B
Figure	  A3.15:	  (A)IsoHematooporphyrin	  redox	  titration	  and	  (B)	  Oxidized	  (black)	  and	  
reduced	  (green)	  spectra.	  Soret	  at	  406nm	  and	  Isosbestic	  point	  at	  452nm
Figure	  A3.16:	  (A)	  Diacetyl	  Deuteroporphyrin	  redox	  titration	  and	  (B)	  Oxidized	  
(black)	  and	  reduced	  (green)	  spectra.	  Soret	  at	  454nm	  and	  Isosbestic	  point	  at	  443nm
135  
      
      
136
0
0.05
0.1
0.15
0.2
0.25
-500 -450 -400 -350 -300 -250 -200 -150 -100
Ab
s 
(5
35
-5
17
)
Eh (mV)
-0.2
0
0.2
0.4
0.6
450 500 550 600 650
Ab
so
rb
an
ce
Wavelength
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
300 350 400 450 500 550 600 650 700
Ab
so
rb
an
ce
Wavelength
-0.06
-0.04
-0.02
0
0.02
0.04
-300 -200 -100 0 100 200 300
Ab
so
rb
an
ce
 (S
or
et
 - 
Is
os
be
st
ic
)
Eh (mV)
A B
Figure	  A3.17:	  (A)	  Tetracarboxyphenylporphyrin	  Spectral-­‐Electrochemical	  titration	  
and	  (B)	  Oxidized	  (black)	  and	  reduced	  (green)	  spectra.	  Difference	  spectrum	  is	  in	  blue
Figure	  A3.18:	  (A)	  Heme	  A	  redox	  titration	  and	  (B)	  Oxidized	  (black)	  and	  reduced	  
(green)	  spectra.	  A	  difference	  spectrum	  (blue)	  was	  added	  for	  clarity.	  Soret	  at	  443nm	  
and	  Isosbestic	  point	  at	  414nm
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A3.4: Zn-Centered Chlorins And Porphyrins
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A3.5: References 
Figure	  A3.19:	  (A)	  Spectra	  of	  Zn-­‐5-­‐Phenyl-­‐15-­‐Carboxyphenyl	  Porphyrin	  (Zn-­‐PCPP)	  in	  
buffer	   (black),	  and	  bound	   to	   the	  Single	  Chain	  protein	  (green).	   A	   difference	  spectra	  
has	   been	  added	   to	   better	   show	   the	  wavelength	  used	   for	   assembly	   studies	   (blue).	  
This	   chlorin	   has	   been	   donated	   by	   the	   laboratory	   of	   Jonathan	   Lindsey	   at	   North	  
Carolina	  State	  university.	  (B)	  Spectra	  of	  SE370	  in	  aqueous	  buffer	  (black)	  and	  bound	  
to	   the	   single	  chain	  protein	  (green).	   (C)	  Newkome	  Solubilized	  Zn-­‐PCPP	  in	  aqueous	  
buffer	  (black)	  and	  bound	  to	  the	  single	  chain	  protein	  (green).	  All	  spectra	  are	  in	  20mM	  
CHES	  150mM	  KCl	  buffer.	  Wavelength	  in	  nm.	  Absorbance	  Normalized	  to	   Soret	  peak,	  
where	  normalized.
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